Neurology

Select a pre-curated test, combine multiple tests, or customize your own test for each patient. Invitae’s pricing is per clinical area for initial order and re-requisition.

The tests and genes on this page are organized into clinical areas. Tests in the Neurology section and on the Cardiology page are in a single clinical area. If your order contains tests from multiple clinical areas, you will need to send in two sample tubes and your order will represent two billable events. Your test results will be delivered as two reports. Please contact Client Services with any questions.

Clinical Area: Neurology

up to 21 genes

Invitae Dystonia Comprehensive Panel

Order

Genetic testing for up to 21 genes associated with dystonia, including the most commonly causative genes.

GENES TESTED:

Primary Panel:
ANO3 ATP1A3 GCH1 GNAL PARK2 PNKD PRKRA PRRT2 SGCE SLC2A1 SLC6A3 SPR TH THAP1 TOR1A TUBB4A

Add-on Preliminary-evidence Genes for Dystonia:
CIZ1 DRD2 HPCA KCTD17 TOR1AIP1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 17 genes

Invitae Hereditary Parkinson's Disease and Parkinsonism Panel

Order

Genetic testing for up to 17 genes associated with Parkinson's disease (PD) and other forms of hereditary parkinsonism. This test covers the most common causative genes for hereditary PD (LRRK2, PARK2, PARK7, PINK1, and SNCA).

GENES TESTED:

Primary Panel:
ATP13A2 DCTN1 DNAJC6 FBXO7 GCH1 LRRK2 PARK2 PARK7 PINK1 PRKRA SLC6A3 SNCA SPR TH VPS35

Add-on Preliminary-evidence Genes for Hereditary Parkinson's Disease and Parkinsonism:
CHCHD2 MAPT

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 27 genes

Invitae Combined Hereditary Dementia and Amyotrophic Lateral Sclerosis Panel

Order

Genetic testing for up to 27 genes associated with dominant, recessive, and X-linked forms of dementia and ALS. This test does not include analysis of the C9orf72 gene.

GENES TESTED:

Primary Panel:
ALS2 APP CHCHD10 DCTN1 FUS GRN MAPT OPTN PFN1 PRNP PSEN1 PSEN2 SNCA SOD1 SPG11 TARDBP TBK1 TFG UBQLN2 VAPB VCP

Add-on Preliminary-evidence Genes for Hereditary Dementia and Amyotrophic Lateral Sclerosis:
CHMP2B HNRNPA2B1 MATR3 SETX SIGMAR1 SQSTM1

The CHMP2B, HNRNPA2B1, MATR3, SETX, SIGMAR1, and SQSTM1 genes currently have early evidence of a clinical association with hereditary dementia and/or ALS. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 19 genes

Invitae Amyotrophic Lateral Sclerosis Panel

Order

Genetic testing for up to 19 genes associated with dominant, recessive, and X-linked forms of ALS. This test does not include analysis of the C9orf72 gene.

GENES TESTED:

Primary Panel:
ALS2 CHCHD10 DCTN1 FUS OPTN PFN1 SOD1 SPG11 TARDBP TBK1 TFG UBQLN2 VAPB

Add-on Preliminary-evidence Genes for Amyotrophic Lateral Sclerosis:
CHMP2B MATR3 SETX SIGMAR1 SQSTM1 VCP

The CHMP2B, MATR3, SETX, SIGMAR1, SQSTM1, and VCP genes currently have preliminary evidence for a clinical association with ALS. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 13 genes

Invitae Frontotemporal Dementia Panel

Order

Genetic testing for up to 13 genes associated with autosomal dominant and X-linked FTD. This test does not include analysis of the C9orf72 gene.

GENES TESTED:

Primary Panel:
CHCHD10 DCTN1 FUS GRN MAPT TARDBP TBK1 UBQLN2 VCP

Add-on Preliminary-evidence Genes for Frontotemporal Dementia:
CHMP2B HNRNPA2B1 PSEN1 SQSTM1

The CHMP2B, HNRNPA2B1, PSEN1, and SQSTM1 genes currently have early evidence of a clinical association with frontotemporal dementia. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

3 genes

Invitae Hereditary Alzheimer's Disease Panel

Order

Genetic testing for the 3 genes most commonly associated with hereditary Alzheimer’s disease.

GENES TESTED:

APP PSEN1 PSEN2

up to 17 genes

Invitae Hereditary Parkinson's Disease and Parkinsonism Panel

Order

Genetic testing for up to 17 genes associated with Parkinson's disease (PD) and other forms of hereditary parkinsonism. This test covers the most common causative genes for hereditary PD (LRRK2, PARK2, PARK7, PINK1, and SNCA).

GENES TESTED:

Primary Panel:
ATP13A2 DCTN1 DNAJC6 FBXO7 GCH1 LRRK2 PARK2 PARK7 PINK1 PRKRA SLC6A3 SNCA SPR TH VPS35

Add-on Preliminary-evidence Genes for Hereditary Parkinson's Disease and Parkinsonism:
CHCHD2 MAPT

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

1 gene

Invitae Hereditary Prion Disease Test

Order

Genetic testing for the PRNP gene, which is the only known cause of hereditary prion disease.

GENES TESTED:

PRNP

Comprehensive Neuromuscular Disorders
up to 121 genes

Invitae Comprehensive Neuromuscular Disorders Panel

Order

Genetic testing for up to 121 genes that are known to be associated with muscular dystrophies, myopathies, and congenital myasthenic syndromes.

GENES TESTED:

Primary Panel:
ACTA1 AGRN ALG2 ANO5 ATP2A1 B3GALNT2 B4GAT1 BAG3 BIN1 CACNA1S CAPN3 CAV3 CCDC78 CFL2 CHAT CHKB CHRNA1 CHRNB1 CHRND CHRNE CLCN1 CNTN1 COL6A1 COL6A2 COL6A3 COLQ CPT2 CRYAB DAG1 DES DMD DNAJB6 DNM2 DOK7 DPAGT1 DPM1 DPM2 DPM3 DYSF EMD FHL1 FKBP14 FKRP FKTN FLNC GAA GFPT1 GMPPB GNE ISPD ITGA7 KBTBD13 KCNJ2 KLHL40 KLHL41 LAMA2 LAMP2 LARGE1 LDB3 LMNA LMOD3 MATR3 MEGF10 MTM1 MUSK MYH2 MYH7 MYL2 MYOT MYPN NEB PLEC PNPLA2 POMGNT1 POMGNT2 POMK POMT1 POMT2 RAPSN RYR1 SCN4A SELENON SGCA SGCB SGCD SGCG SMN1, SMN2 SQSTM1 STAC3 STIM1 TAZ TCAP TIA1 TMEM5 TNNT1 TNPO3 TPM2 TPM3 TRAPPC11 TRIM32 TTN VCP VMA21

Add-on Preliminary-evidence Genes for Neuromuscular Disorders:
ALG14 COL12A1 HNRNPA2B1 HNRNPDL LAMB2 LIMS2 LRP4 MYF6 PREPL SNAP25 SUN1 SUN2 SYNE1 SYNE2 TMEM43 TOR1AIP1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Add-on Facioscapulohumeral Muscular Dystrophy Type 2 (FSHD2) Gene:
SMCHD1

Pathogenic variants in SMCHD1 account for approximately 5% of facioscapulohumeral muscular dystrophy. SMCHD1 variants should be interpreted in the context of D4Z4 hypomethylation and a permissive 4qA haplotype, which is not part of this assay. Depending on the clinical presentation of the individual and within the context of additional laboratory results, clinicians may wish to broaden analysis by including this gene, which can be added at no additional charge.

Congenital Myasthenic Syndrome
up to 21 genes

Invitae Congenital Myasthenic Syndrome Panel

Order

Genetic testing for up to 21 genes that are known to be associated with congenital myasthenic syndrome (CMS).

GENES TESTED:

Primary Panel:
AGRN ALG2 CHAT CHRNA1 CHRNB1 CHRND CHRNE COLQ DOK7 DPAGT1 GFPT1 MUSK RAPSN

Add-on Preliminary-evidence Genes for Congenital Myasthenic Syndrome:
ALG14 GMPPB LAMB2 LRP4 PLEC PREPL SCN4A SNAP25

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Malignant Hyperthermia Susceptibility
2 genes

Invitae Malignant Hyperthermia Susceptibility Panel

Order

Genetic testing for the two genes that are currently known to be associated with malignant hyperthermia susceptibility (MHS).

GENES TESTED:

CACNA1S RYR1

Muscular Dystrophy
up to 56 genes

Invitae Comprehensive Muscular Dystrophy Panel

Order

Genetic testing for up to 56 genes that are known to be associated with muscular dystrophies.

GENES TESTED:

Primary Panel:
ANO5 B3GALNT2 B4GAT1 CAPN3 CAV3 CHKB COL6A1 COL6A2 COL6A3 DAG1 DES DMD DNAJB6 DPM1 DPM2 DPM3 DYSF EMD FHL1 FKRP FKTN GAA GMPPB ISPD ITGA7 LAMA2 LARGE1 LMNA MYOT PLEC PNPLA2 POMGNT1 POMGNT2 POMK POMT1 POMT2 SGCA SGCB SGCD SGCG TCAP TMEM5 TNPO3 TRAPPC11 TRIM32 TTN

Add-on Preliminary-evidence Genes for Muscular Dystrophy:
COL12A1 HNRNPDL LIMS2 SUN1 SUN2 SYNE1 SYNE2 TMEM43 TOR1AIP1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Add-on Facioscapulohumeral Muscular Dystrophy Type 2 (FSHD2) Gene:
SMCHD1

Pathogenic variants in SMCHD1 account for approximately 5% of facioscapulohumeral muscular dystrophy. SMCHD1 variants should be interpreted in the context of D4Z4 hypomethylation and a permissive 4qA haplotype, which is not part of this assay. Depending on the clinical presentation of the individual and within the context of additional laboratory results, clinicians may wish to broaden analysis by including this gene, which can be added at no additional charge.

up to 27 genes

Invitae Congenital Muscular Dystrophy Panel

Order

Genetic testing for up to 27 genes that are known to be associated with congenital muscular dystrophies (CMDs).

GENES TESTED:

Primary Panel:
B3GALNT2 B4GAT1 CHKB COL6A1 COL6A2 COL6A3 DAG1 DMD DPM1 DPM2 DPM3 FKRP FKTN GMPPB ISPD ITGA7 LAMA2 LARGE1 LMNA POMGNT1 POMGNT2 POMK POMT1 POMT2 TCAP TMEM5

Add-on Preliminary-evidence Gene for Congenital Muscular Dystrophy:
COL12A1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include a gene which does not currently have a definitive clinical association, but which may prove to be clinically significant in the future. This gene can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

17 genes

Invitae Dystroglycanopathy Panel

Order

Genetic testing for 17 genes that are known to be associated with muscular dystrophy-dystroglycanopathies.

GENES TESTED:

B3GALNT2 B4GAT1 DAG1 DPM1 DPM2 DPM3 FKRP FKTN GMPPB ISPD LARGE1 POMGNT1 POMGNT2 POMK POMT1 POMT2 TMEM5

1 gene

Invitae Dystrophinopathies Test

Order

Genetic testing for DMD, associated with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and dilated cardiomyopathy (DCM).

GENES TESTED:

DMD

up to 8 genes

Invitae Emery-Dreifuss Muscular Dystrophy Panel

Order

Genetic testing for up to eight genes that are known to be associated with Emery-Dreifuss muscular dystrophy (EDMD).

GENES TESTED:

Primary Panel:
EMD FHL1 LMNA

Add-on Preliminary-evidence Genes for Emery-Dreifuss Muscular Dystrophy:
SUN1 SUN2 SYNE1 SYNE2 TMEM43

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 34 genes

Invitae Limb-Girdle Muscular Dystrophy Panel

Order

Genetic testing for up to 34 genes that are known to be associated with limb-girdle muscular dystrophy (LGMD). This test covers the most common causative genes.

GENES TESTED:

Primary Panel:
ANO5 CAPN3 CAV3 DAG1 DES DMD DNAJB6 DYSF FKRP FKTN GAA GMPPB ISPD LMNA MYOT PLEC PNPLA2 POMGNT1 POMK POMT1 POMT2 SGCA SGCB SGCD SGCG TCAP TNPO3 TRAPPC11 TRIM32 TTN

Add-on Preliminary-evidence Genes for Limb-Girdle Muscular Dystrophy:
HNRNPDL LIMS2 TOR1AIP1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Add-on Facioscapulohumeral Muscular Dystrophy Type 2 (FSHD2) Gene:
SMCHD1

Pathogenic variants in SMCHD1 account for approximately 5% of facioscapulohumeral muscular dystrophy. SMCHD1 variants should be interpreted in the context of D4Z4 hypomethylation and a permissive 4qA haplotype, which is not part of this assay. Depending on the clinical presentation of the individual and within the context of additional laboratory results, clinicians may wish to broaden analysis by including this gene, which can be added at no additional charge.

Myopathy
up to 52 genes

Invitae Comprehensive Myopathy Panel

Order

Genetic testing for up to 52 genes that are known to be associated with myopathy. This test includes the most common causative genes.

GENES TESTED:

Primary Panel:
ACTA1 ANO5 ATP2A1 BAG3 BIN1 CACNA1S CAV3 CCDC78 CFL2 CNTN1 COL6A1 COL6A2 COL6A3 CPT2 CRYAB DES DNAJB6 DNM2 DYSF FHL1 FKBP14 FLNC GNE KBTBD13 KCNJ2 KLHL40 KLHL41 LDB3 LMNA LMOD3 MATR3 MEGF10 MTM1 MYH7 MYL2 MYOT MYPN NEB RYR1 SCN4A SELENON SQSTM1 STAC3 STIM1 TIA1 TNNT1 TPM2 TPM3 TTN VCP

Add-on Preliminary-evidence Genes for Myopathy:
COL12A1 MYF6

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 28 genes

Invitae Congenital Myopathy Panel

Order

Genetic testing for up to 28 genes that are known to be associated with congenital myopathies. This test includes the most common causative genes.

GENES TESTED:

Primary Panel:
ACTA1 BIN1 CCDC78 CFL2 CNTN1 COL6A1 COL6A2 COL6A3 DNM2 FKBP14 KBTBD13 KLHL40 KLHL41 LMOD3 MEGF10 MTM1 MYH7 MYPN NEB RYR1 SELENON STAC3 TNNT1 TPM2 TPM3 TTN

Add-on Preliminary-evidence Genes for Congenital Myopathy:
COL12A1 MYF6

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

3 genes

Invitae Autophagic Vacuolar Myopathy Panel

Order

Genetic testing for three genes associated with autophagic vacuolar myopathies (AVM).

GENES TESTED:

DES LAMP2 VMA21

1 gene

Invitae Central Core Disease Test

Order

Genetic testing for the RYR1 gene, which is associated with central core disease—a condition that is characterized by muscle weakness and the presence of central cores upon muscle biopsy.

GENES TESTED:

RYR1

up to 7 genes

Invitae Centronuclear Myopathy Panel

Order

Genetic testing for up to seven genes that are known to be associated with centronuclear myopathy (CNM).

GENES TESTED:

Primary Panel:
BIN1 CCDC78 DNM2 MTM1 RYR1 TTN

Add-on Preliminary-evidence Gene for Centronuclear Myopathy:
MYF6

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include a gene which does not currently have a definitive clinical association, but which may prove to be clinically significant in the future. This gene can be added at no additional charge. Visit our “(external) Preliminary-evidence genes”:/preliminary-evidence/ page to learn more.

7 genes

Invitae Congenital Fiber-Type Disproportion Panel

Order

Genetic testing for seven genes that are known to be associated with congenital fiber-type disproportion (CFTD).

GENES TESTED:

ACTA1 LMNA MYH7 RYR1 SELENON TPM2 TPM3

18 genes

Invitae Distal Myopathy Panel

Order

Genetic testing for 18 genes that are known to be associated with distal myopathy.

GENES TESTED:

ANO5 BAG3 CAV3 CRYAB DES DNAJB6 DYSF FHL1 FLNC GNE LDB3 MATR3 MYH7 MYOT SQSTM1 TIA1 TTN VCP

1 gene

Invitae Hyperkalemic Periodic Paralysis Test

Order

Genetic testing for SCN4A, which is the only gene known to be associated with hyperkalemic periodic paralysis (HYPP).

GENES TESTED:

SCN4A

3 genes

Invitae Periodic Paralysis Panel

Order

Genetic testing for three genes that are associated with periodic paralysis.

GENES TESTED:

CACNA1S KCNJ2 SCN4A

up to 5 genes

Invitae Inclusion Body Myopathy Panel

Order

Genetic testing for up to five genes associated with inclusion body myopathies (IBM).

GENES TESTED:

Primary Panel:
GNE MYH2 TTN VCP

Add-on Preliminary-evidence Gene for Inclusion Body Myopathy:
HNRNPA2B1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include a gene which does not currently have a definitive clinical association, but which may prove to be clinically significant in the future. This gene can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

2 genes

Invitae Multiminicore Disease Panel

Order

Genetic testing for both genes that are known to be associated with multiminicore disease (MmD).

GENES TESTED:

RYR1 SELENON

8 genes

Invitae Myofibrillar Myopathy Panel

Order

Genetic testing for eight genes that are known to be associated with myofibrillar myopathy.

GENES TESTED:

BAG3 CRYAB DES DNAJB6 FHL1 FLNC LDB3 MYOT

11 genes

Invitae Nemaline Myopathy Panel

Order

Genetic testing for 11 genes that are known to be associated with nemaline myopathy.

GENES TESTED:

ACTA1 CFL2 KBTBD13 KLHL40 KLHL41 LMOD3 MYPN NEB TNNT1 TPM2 TPM3

up to 4 genes

Invitae Type VI Collagenopathy Panel

Order

Genetic testing for up to four genes that are known to be associated with type VI collagenopathies including Bethlem myopathy 1 (BTHLM1) and Ullrich congenital muscular dystrophy 1 (UCMD1).

GENES TESTED:

Primary Panel:
COL6A1 COL6A2 COL6A3

Add-on Preliminary-evidence Gene for Type VI Collagenopathy:
COL12A1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include a gene which does not currently have a definitive clinical association, but which may prove to be clinically significant in the future. This gene can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Myotonia Congenita
2 genes

Invitae Myotonia and Paramyotonia Congenita Panel

Order

Genetic testing for 2 genes that cause myotonia and paramyotonia congenita. This test covers the most common causative genes for these disorders.

GENES TESTED:

CLCN1 SCN4A

Spinal Muscular Atrophy
2 genes

Invitae Spinal Muscular Atrophy Panel

Order

Genetic testing for two genes: SMN1, which is associated with spinal muscular atrophy (SMA), and SMN2, which modifies clinical phenotype.

GENES TESTED:

SMN1, SMN2

Comprehensive Neuropathies
up to 83 genes

Invitae Comprehensive Neuropathies Panel

Order

Genetic testing for up to 83 genes that cause dominant, recessive, and X-linked hereditary neuropathies including Charcot-Marie-Tooth disease (CMT), hereditary motor neuropathies and hereditary sensory and autonomic neuropathies (HSAN).

GENES TESTED:

Primary Panel:
AARS AIFM1 ATL1 ATL3 ATP7A BICD2 BSCL2 CHCHD10 DCTN1 DNAJB2 DNM2 DNMT1 DST DYNC1H1 EGR2 FAM134B FBXO38 FGD4 FIG4 GAN GARS GDAP1 GJB1 GNB4 HARS HINT1 HSPB1 HSPB8 IGHMBP2 IKBKAP INF2 KIF1A LITAF LMNA LRSAM1 MED25 MFN2 MORC2 MPZ MTMR2 NDRG1 NEFL NGF NTRK1 PDK3 PLEKHG5 PMP22 PRPS1 PRX RAB7A REEP1 SBF2 SCN11A SCN9A SH3TC2 SIGMAR1 SLC52A2 SLC52A3 SLC5A7 SPG11 SPTLC1 SPTLC2 TFG TRIM2 TRPV4 TTR UBA1 VAPB WNK1 YARS

Add-on Preliminary-evidence Genes for Neuropathies:
CCT5 FLRT1 HSPB3 LAS1L MARS PRDM12 SCN10A SETX SLC25A46 SURF1 VRK1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Add-on Spinal Muscular Atrophy Genes:
SMN1, SMN2

SMN1-related spinal muscular atrophy (SMA) is the most common form of proximal SMA and is one of the most common autosomal recessive diseases. It presents differently than distal spinal muscular atrophy (DSMA), also known as dHMN or HMN, which is characterized by slowly progressive symmetrical and predominantly distal limb weakness. Depending on the clinical presentation of the patient, clinicians may wish to broaden analysis by including these genes. These genes can be added at no additional charge.

Charcot-Marie-Tooth Disease
up to 45 genes

Invitae Charcot-Marie-Tooth Disease Comprehensive Panel

Order

Genetic testing for up to 45 genes that cause dominant, recessive, and X-linked Charcot-Marie-Tooth disease (CMT). This test covers the most common causative genes.

GENES TESTED:

Primary Panel:
AARS AIFM1 BSCL2 DNAJB2 DNM2 DYNC1H1 EGR2 FGD4 FIG4 GARS GDAP1 GJB1 GNB4 HARS HINT1 HSPB1 HSPB8 IGHMBP2 INF2 LITAF LMNA LRSAM1 MED25 MFN2 MORC2 MPZ MTMR2 NDRG1 NEFL PDK3 PLEKHG5 PMP22 PRPS1 PRX RAB7A SBF2 SH3TC2 SPG11 TFG TRIM2 TRPV4 YARS

Add-on Preliminary-evidence Genes for Charcot-Marie-Tooth Disease:
MARS SLC25A46 SURF1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 25 genes

Invitae Charcot-Marie-Tooth Disease Autosomal Dominant Panel

Order

Genetic testing for up to 25 genes that cause Charcot-Marie-Tooth disease (CMT) with dominant inheritance. This panel includes the most commonly causative genes.

GENES TESTED:

Primary Panel:
AARS BSCL2 DNM2 DYNC1H1 EGR2 GARS GDAP1 GNB4 HARS HSPB1 HSPB8 INF2 LITAF LMNA LRSAM1 MFN2 MORC2 MPZ NEFL PMP22 RAB7A TFG TRPV4 YARS

Add-on Preliminary-evidence Genes for Charcot-Marie-Tooth Disease Autosomal Dominant:
MARS

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 22 genes

Invitae Charcot-Marie-Tooth Disease Autosomal Recessive Panel

Order

Genetic testing for up to 22 genes that cause Charcot-Marie-Tooth disease (CMT) with recessive inheritance. This panel includes the most commonly causative genes.

GENES TESTED:

Primary Panel:
DNAJB2 EGR2 FGD4 FIG4 GDAP1 HINT1 IGHMBP2 LMNA LRSAM1 MED25 MFN2 MTMR2 NDRG1 NEFL PLEKHG5 PRX SBF2 SH3TC2 SPG11 TRIM2

Add-on Preliminary-evidence Genes for Charcot-Marie-Tooth Disease Autosomal Recessive:
SLC25A46 SURF1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

4 genes

Invitae Charcot-Marie-Tooth Disease X-linked Panel

Order

Genetic testing for four genes that cause Charcot-Marie-Tooth (CMT) disease with X-linked inheritance. This panel includes the most commonly causative genes.

GENES TESTED:

AIFM1 GJB1 PDK3 PRPS1

Hereditary Sensory and Autonomic Neuropathy
up to 17 genes

Invitae Hereditary Sensory and Autonomic Neuropathy Panel

Order

Genetic testing for up to 17 genes that are known to be associated with hereditary sensory and autonomic neuropathy (HSAN) and hereditary sensory neuropathy (HSN).

GENES TESTED:

Primary Panel:
ATL1 ATL3 DNMT1 DST FAM134B IKBKAP KIF1A NGF NTRK1 RAB7A SCN11A SCN9A SPTLC1 SPTLC2 WNK1

Add-on Preliminary-evidence Genes for Hereditary Sensory and Autonomic Neuropathy:
CCT5 PRDM12

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

1 gene

Invitae Familial Dysautonomia Test

Order

Genetic testing for IKBKAP deletions/duplications and sequence variants which cause familial dysautonomia (FD).

GENES TESTED:

IKBKAP

Motor Neuropathy
up to 24 genes

Invitae Hereditary Motor Neuropathy Panel

Order

Genetic testing for up to 24 genes that are known to be associated with proximal or distal hereditary motor neuropathy (HMN).

GENES TESTED:

Primary Panel:
ATP7A BICD2 BSCL2 CHCHD10 DCTN1 DNAJB2 DYNC1H1 FBXO38 GARS HINT1 HSPB1 HSPB8 IGHMBP2 PLEKHG5 REEP1 SIGMAR1 SLC5A7 SMN1, SMN2 TRPV4 UBA1 VAPB

Add-on Preliminary-evidence Genes for Hereditary Motor Neuropathy:
HSPB3 VRK1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

2 genes

Invitae Spinal Muscular Atrophy Panel

Order

Genetic testing for two genes: SMN1, which is associated with spinal muscular atrophy (SMA), and SMN2, which modifies clinical phenotype.

GENES TESTED:

SMN1, SMN2

Small Fiber Neuropathy
up to 2 genes

Invitae Small Fiber Neuropathy Test

Order

Genetic testing for up to two genes that are known to be associated with small fiber neuropathy (SFNP).

GENES TESTED:

Primary Panel:
SCN9A

Add-on Preliminary-evidence Gene for Small Fiber Neuropathy:
SCN10A

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include a gene which does not currently have a definitive clinical association, but which may prove to be clinically significant in the future. This gene can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Riboflavin Transporter Deficiency Neuronopathy
2 genes

Invitae Riboflavin Transporter Deficiency Neuronopathy Panel

Order

Genetic testing for two genes that cause riboflavin transporter deficiency neuronopathy, also known as Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. This test covers all known causative genes.

GENES TESTED:

SLC52A2 SLC52A3

Hereditary Spastic Paraplegia
up to 64 genes

Invitae Hereditary Spastic Paraplegia Comprehensive Panel

Order

Genetic testing for up to 64 genes that cause dominant, recessive, and X-linked hereditary spastic paraplegia (HSP), including the most commonly causative genes.

GENES TESTED:

Primary Panel:
ABCD1 ALDH18A1 ALS2 AP4B1 AP4E1 AP4M1 AP4S1 AP5Z1 ATL1 B4GALNT1 BSCL2 C12orf65 CYP2U1 CYP7B1 DDHD1 DDHD2 ERLIN2 FA2H GBA2 GJC2 HSPD1 KDM5C KIF1A KIF1C KIF5A L1CAM NIPA1 NT5C2 PLP1 PNPLA6 REEP1 RTN2 SACS SLC16A2 SPAST SPG11 SPG20 SPG21 SPG7 TECPR2 VAMP1 WASHC5 ZFYVE26

Add-on Preliminary-evidence Genes for Hereditary Spastic Paraplegia:
AMPD2 ARL6IP1 ARSI ATP13A2 C19orf12 CCT5 CPT1C ENTPD1 ERLIN1 EXOSC3 IBA57 MAG PGAP1 RAB3GAP2 REEP2 SLC33A1 TFG USP8 VPS37A ZFR ZFYVE27

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 16 genes

Invitae Hereditary Spastic Paraplegia Autosomal Dominant Panel

Order

Genetic testing for up to 16 genes that cause autosomal dominant hereditary spastic paraplegia (HSP), including the most commonly causative genes.

GENES TESTED:

Primary Panel:
ALDH18A1 ATL1 BSCL2 HSPD1 KIF1A KIF5A NIPA1 REEP1 RTN2 SPAST VAMP1 WASHC5

Add-on Preliminary-evidence Genes for Hereditary Spastic Paraplegia Autosomal Dominant:
CPT1C REEP2 SLC33A1 ZFYVE27

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 46 genes

Invitae Hereditary Spastic Paraplegia Autosomal Recessive Panel

Order

Genetic testing for up to 46 genes that cause autosomal recessive hereditary spastic paraplegia (HSP), including the most commonly causative genes.

GENES TESTED:

Primary Panel:
ALDH18A1 ALS2 AP4B1 AP4E1 AP4M1 AP4S1 AP5Z1 B4GALNT1 C12orf65 CYP2U1 CYP7B1 DDHD1 DDHD2 ERLIN2 FA2H GBA2 GJC2 KIF1A KIF1C NT5C2 PNPLA6 SACS SPG11 SPG20 SPG21 SPG7 TECPR2 ZFYVE26

Add-on Preliminary-evidence Genes for Hereditary Spastic Paraplegia Autosomal Recessive:
AMPD2 ARL6IP1 ARSI ATP13A2 C19orf12 CCT5 ENTPD1 ERLIN1 EXOSC3 IBA57 MAG PGAP1 RAB3GAP2 REEP2 TFG USP8 VPS37A ZFR

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

5 genes

Invitae Hereditary Spastic Paraplegia X-linked Panel

Order

Genetic testing for 5 genes that cause X-linked hereditary spastic paraplegia (HSP).

GENES TESTED:

ABCD1 KDM5C L1CAM PLP1 SLC16A2

up to 158 genes

Invitae Cardiomyopathy and Skeletal Muscle Disease Panel

Order

Genetic testing for up to 158 genes that are known to be associated with either cardiomyopathy or skeletal myopathy.

GENES TESTED:

Primary Panel:
ABCC9 ACTA1 ACTC1 ACTN2 AGL ANO5 ATP2A1 B3GALNT2 B4GAT1 BAG3 BIN1 CACNA1C CAPN3 CAV3 CCDC78 CFL2 CHKB CNTN1 COL6A1 COL6A2 COL6A3 CPT2 CRYAB CSRP3 DAG1 DES DMD DNAJB6 DNM2 DOLK DPM1 DPM2 DPM3 DSC2 DSG2 DSP DYSF EMD EYA4 FHL1 FKBP14 FKRP FKTN FLNC GAA GLA GMPPB GNE HCN4 ISPD ITGA7 JUP KBTBD13 KLHL40 KLHL41 LAMA2 LAMP2 LARGE1 LMNA LMOD3 MATR3 MEGF10 MTM1 MYBPC3 MYH7 MYL2 MYL3 MYOT MYPN NEB PKP2 PLEC PLN PNPLA2 POMGNT1 POMGNT2 POMK POMT1 POMT2 PRKAG2 RAF1 RBM20 RYR1 RYR2 SCN5A SELENON SGCA SGCB SGCD SGCG SLC22A5 SQSTM1 STAC3 STIM1 TAZ TCAP TIA1 TMEM43 TMEM5 TNNC1 TNNI3 TNNT1 TNNT2 TNPO3 TPM1 TPM2 TPM3 TRAPPC11 TRIM32 TTN TTR VCL VCP

Add-on Preliminary-evidence Genes for Cardiomyopathy and Skeletal Muscle Disease:
ANKRD1 CALR3 CHRM2 COL12A1 CTF1 CTNNA3 DTNA FHL2 GATA4 GATA6 GATAD1 HNRNPDL ILK JPH2 LAMA4 LDB3 LIMS2 LRRC10 MYF6 MYH6 MYLK2 MYOM1 MYOZ2 NEBL NEXN NKX2-5 NPPA PDLIM3 PLEKHM2 PRDM16 SUN1 SUN2 SYNE1 SYNE2 TGFB3 TMPO TOR1AIP1 TXNRD2

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Add-on Autosomal Recessive Syndromic Pediatric Cardiomyopathy Genes:
ACADVL ALMS1 DNAJC19 ELAC2 MTO1 SDHA TMEM70

Genes associated with early-onset cardiomyopathy as part of an autosomal recessive disorder may be included at no additional charge. Clinicians may wish to include these genes for patients who present in infancy or early childhood with clinical features of a multi-system disorder. Please note, SDHA is included due to its association with autosomal recessive mitochondrial complex II deficiency. However, SDHA is most commonly associated with autosomal dominant predisposition to cancer.

Clinical Area: Pediatric and Rare Disease

up to 189 genes

Invitae Epilepsy Panel

Order

Genetic testing for up to 189 genes associated with syndromic and nonsyndromic causes of epilepsy, a common neurological disease characterized by recurrent unprovoked seizures.

GENES TESTED:

Primary Panel:
ADSL ALDH5A1 ALDH7A1 ALG13 ARHGEF9 ARX ATP1A2 ATP1A3 ATRX BRAT1 C12orf57 CACNA2D2 CASK CDKL5 CHD2 CHRNA2 CHRNA4 CHRNB2 CLN2 (TPP1) CLN3 CLN5 CLN6 CLN8 CNTNAP2 CSTB CTSD DEPDC5 DNAJC5 DNM1 DYRK1A EEF1A2 EFHC1 EHMT1 EPM2A FOLR1 FOXG1 FRRS1L GABRA1 GABRB3 GABRG2 GAMT GATM GLRA1 GNAO1 GOSR2 GRIN1 GRIN2A GRIN2B HCN1 HNRNPU IER3IP1 IQSEC2 ITPA KANSL1 KCNA2 KCNB1 KCNC1 KCNH2 KCNJ10 KCNQ2 KCNQ3 KCNT1 KCTD7 KIAA2022 LGI1 LIAS MBD5 MECP2 MEF2C MFSD8 NGLY1 NHLRC1 NRXN1 PACS1 PCDH19 PIGA PIGN PIGO PLCB1 PNKD PNKP PNPO POLG PPT1 PRICKLE1 PRRT2 PURA QARS ROGDI SATB2 SCARB2 SCN1A SCN1B SCN2A SCN3A SCN8A SCN9A SERPINI1 SGCE SLC13A5 SLC19A3 SLC25A22 SLC2A1 SLC35A2 SLC6A1 SLC6A8 SLC9A6 SMC1A SNX27 SPATA5 SPTAN1 STX1B STXBP1 SYN1 SYNGAP1 SYNJ1 SZT2 TBC1D24 TCF4 TSC1 TSC2 UBE3A WWOX ZDHHC9 ZEB2

Add-on Preliminary-evidence Genes for Epilepsy:
ABAT ARHGEF15 ATP6AP2 CACNA1A CACNA1H CACNB4 CARS2 CASR CBL CERS1 CLCN4 CNTN2 COQ4 CPA6 DIAPH1 DOCK7 FARS2 FASN GABBR2 GABRB2 GABRD GAL GPHN JMJD1C KCNA1 KCND2 KCNH5 KCNMA1 KPNA7 LMNB2 MTOR NECAP1 NEDD4L NPRL3 PIGG PIGQ PIK3AP1 PRDM8 PRICKLE2 PRIMA1 RBFOX1 RBFOX3 RELN RYR3 SCN5A SETD2 SIK1 SLC12A5 SLC25A12 SLC35A3 SNAP25 SRPX2 ST3GAL3 ST3GAL5 STRADA TBL1XR1 TPK1 WDR45

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

Add-on Genes for Glycine Encephalopathy:
AMT GCSH GLDC

In addition to the primary panel, clinicians can choose to include three genes that are associated with glycine encephalopathy, which can cause encephalopathy, hypotonia, seizures, and elevated plasma and CSF glycine levels. If clinically indicated, these gene can be added at no additional charge.

Add-on FLNA Gene:
FLNA

In addition to the primary Epilepsy panel, clinicians can choose to include the FLNA gene that is associated with disorders that are broadly categorized as neuronal migration disorders and otopalatodigital spectrum disorders. Periventricular nodular heterotopia is a neuronal migration disorder characterized by seizures and nodules lining the edges of the lateral cerebral ventricles, along with variable presence of persistent patent ductus arteriosus, coagulopathy, connective tissue and vascular anomalies, and/or gastrointestinal dysmotility (PMID: 15917206, 19917821). Periventricular nodular heterotopia predominantly affects females due to the severity of this condition in males (PMID: 15917206). If clinically indicated, this gene can be added at no additional charge.

Add-on PTEN Gene:
PTEN

In addition to the primary Epilepsy panel, clinicians can choose to include the PTEN gene that is associated with PTEN-related autism spectrum disorder (ASD), with or without macrocephaly. ASDs are characterized by impairments in social interactions and communication, developmental delays, and restricted and/or repetitive behaviors. Autism is often associated with other neurological conditions including epilepsy (PMID: 20510557, 24580998). If clinically indicated, this gene can be added at no additional charge.

Add-on RANBP2 Gene:
RANBP2

In addition to the primary panel, clinicians can choose to include the RANBP2 gene that is associated with infection-induced acute necrotizing encephalopathy, an environmentally triggered disease in which previously healthy children develop encephalopathy, seizures, and rapid progression to coma, typically within days of onset of a common febrile infection (PMID: 19118815). If clinically indicated, this gene can be added at no additional charge.

up to 5 genes

Invitae Alternating Hemiplegia of Childhood Panel

Order

Genetic testing for two genes that are associated with alternating hemiplegia of childhood (AHC), a rare neurological condition characterized by childhood onset of recurrent hemi- or quadriplegia, progressive cognitive decline and other variable neurological findings including dystonia, choreoathetoid movements, and seizures.

GENES TESTED:

Primary Panel:
ATP1A2 ATP1A3

Add-on Clinically-overlapping Genes:
CACNA1A SCN1A SLC2A1

AHC can clinically overlap with other disorders including familial hemiplegic migraine (FHM) and GLUT1 deficiency. In addition to the primary panel, clinicians can choose to include these clinically overlapping genes. FHM is characterized by migraine headaches with aura and affected individuals may also experience hemiparesis, seizures, ataxia, fever, visual and speaking difficulties, confusion, and loss of consciousness (PMID: 24498617, 18028456, 16437583, 18644608, 12953268, 16110494). Classic GLUT1 deficiency is characterized by infantile or childhood-onset treatment-resistant epilepsy, intellectual disability, microcephaly, complex movement disorders, and low cerebrospinal fluid glucose levels (PMID: 19304421). If clinically indicated, these gene can be added at no additional charge.

2 genes

Invitae Baraitser-Winter Cerebrofrontofacial Syndrome Panel

Order

Genetic testing for two genes known to be associated with Baraitser-Winter cerebrofrontofacial (BWCFF) syndrome, which is characterized by distinctive craniofacial features and intellectual disability.

GENES TESTED:

ACTB ACTG1

3 genes

Invitae Cerebral Cavernous Malformations Panel

Order

Genetic testing for three genes that are associated with familial cerebral cavernous malformations (CCM).

GENES TESTED:

CCM2 KRIT1 PDCD10

1 gene

Invitae CHARGE Syndrome Test

Order

Genetic testing for CHD7, the gene associated with CHARGE syndrome. CHARGE syndrome is characterized by coloboma, heart defect, choanal atresia, retarded growth and development, genital abnormalities, and ear anomalies.

GENES TESTED:

CHD7

up to 63 genes

Invitae Early Infantile Epileptic Encephalopathy Panel

Order

Genetic testing for up to 63 genes associated with early infantile epileptic encephalopathy (EIEE, also known as Ohtahara syndrome), a condition commonly characterized by intractable seizures within the first three months of life and a classic EEG suppression-burst pattern.

GENES TESTED:

Primary Panel:
ALDH7A1 ARHGEF9 ARX BRAT1 CACNA2D2 CASK CDKL5 CHD2 DNM1 EEF1A2 FOLR1 FRRS1L GABRA1 GABRB3 GNAO1 GRIN1 GRIN2B HCN1 HNRNPU IER3IP1 KCNA2 KCNB1 KCNQ2 KCNQ3 KCNT1 PCDH19 PIGA PIGN PIGO PLCB1 PNKP PNPO PURA SCN1A SCN2A SCN8A SCN9A SLC13A5 SLC25A22 SLC2A1 SLC35A2 SLC6A1 SMC1A SPTAN1 STXBP1 SYNGAP1 SZT2 TBC1D24 WWOX

Add-on Preliminary-evidence Genes for Early Infantile Epileptic Encephalopathy:
ARHGEF15 CLCN4 COQ4 DOCK7 GABBR2 GPHN KCNH5 MTOR NECAP1 NEDD4L SCN1B SIK1 SLC12A5 ST3GAL3

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 9 genes

Invitae Holoprosencephaly Panel

Order

Genetic testing for up to nine genes that are associated with holoprosencephaly (HPE), a spectrum of brain malformations ranging from a single central upper incisor to complete failed separation of the cerebral hemispheres.

GENES TESTED:

Primary Panel:
GLI2 SHH SIX3 TGIF1 ZIC2

Add-on Preliminary-evidence Genes for Holoprosencephaly:
CDON FOXH1 NODAL PTCH1

Preliminary-evidence genes currently have early evidence of a clinical association with the specific disease covered by this test. Some clinicians may wish to include genes which do not currently have a definitive clinical association, but which may prove to be clinically significant in the future. These genes can be added at no additional charge. Visit our Preliminary-evidence genes page to learn more.

up to 14 genes

Invitae Neurodegeneration with Brain Iron Accumulation Panel

Order

Genetic testing for up to 14 genes that are associated with neurodegeneration with brain iron accumulation (NBIA).

GENES TESTED:

Primary Panel:
ATP13A2 C19orf12 COASY CP DCAF17 FTL FUCA1 PANK2 PLA2G6 SQSTM1 WDR45

Add-on Preliminary-evidence Genes for Neurodegeneration with Brain Iron Accumulation:
FA2H KIF1A TRIM32

In addition to the primary panel, clinicians can also choose to include three genes that have preliminary evidence of association with NBIA. At this time, the association of these three genes with NBIA remains preliminary. However, some clinicians may wish to include genes that may prove to be clinically significant in the future. Visit our Preliminary-evidence genes page to learn more.

up to 26 genes

Invitae Rett and Angelman Syndromes and Related Disorders Panel

Order

Genetic testing for up to 26 genes associated with Rett and Angelman syndromes and related early-onset developmental disorders in which epilepsy, developmental delay and intellectual disability are prominent findings.

GENES TESTED:

Primary Panel:
ADSL ALDH5A1 ATRX CDKL5 CNTNAP2 DYRK1A EHMT1 FOXG1 IQSEC2 KANSL1 MBD5 MECP2 MEF2C NGLY1 NRXN1 SATB2 SCN8A SLC9A6 STXBP1 TCF4 UBE3A ZEB2

Add-on Preliminary-evidence Genes for Rett and Angelman Syndromes and Related Disorders:
GABRD JMJD1C TBL1XR1 WDR45

In addition to the primary panel, clinicians can also choose to include genes that have preliminary evidence of association with early-onset developmental disorders that overlap with Rett and Angelman syndromes. However, some clinicians may wish to include genes that may prove to be clinically significant in the future. Visit our Preliminary-evidence genes page to learn more.

2 genes

Invitae Tuberous Sclerosis Complex Panel

Order

Genetic testing for TSC1 and TSC2 which are associated with tuberous sclerosis complex (TSC) featuring kidney, brain, skin, lung, and heart tumors.

GENES TESTED:

TSC1 TSC2

To add genes to your cart, first select a clinical area to see available combinations

  • Clinical Area: Neurology
  • Clinical Area: Pediatric and Rare Disease

Gene
A

The AARS gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2N (CMT2N) (MedGen UID: 413754).

Synonym(s): GABA-AT; GABAT; NPD009

The ABAT gene is associated with autosomal recessive GABA-transaminase (GABA-T) deficiency (PMID: 20052547).

The ABCC9 gene is associated with autosomal dominant Cantu syndrome (MedGen UID: 208647), dilated cardiomyopathy (DCM) (MedGen UID: 325268), Brugada syndrome (BrS) (PMID: 24439875), and atrial fibrillation (MedGen UID: 481325).

Synonym(s): ABC42; ALD; ALDP; AMN

The ABCD1 gene is associated with X-linked adrenoleukodystrophy (ALD) (MedGen UID: 57667).

Synonym(s): ACAD6; LCACD; VLCAD

The ACADVL gene is associated with autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency (MedGen UID: 87459).

Synonym(s): ACTA

The ACTA1 gene is associated with autosomal dominant and recessive nemaline myopathy 3 (NEM3) (MedGen UID: 371799) and autosomal dominant congenital fiber-type disproportion (CFTD) (MedGen UID: 108177). Other ACTA1-related disorders have also been reported (OMIM: 102610).

Synonym(s): BRWS1; PS1TP5BP1

The ACTB gene is associated with autosomal dominant Baraitser-Winter cerebrofrontofacial (BWCFF) syndrome (MedGen UID: 340943). Additionally, the ACTB gene has preliminary evidence supporting a correlation with juvenile-onset dystonia (PMID: 25052316, 16685646).

Synonym(s): ACTC; ASD5; CMD1R; CMH11; LVNC4

The ACTC1 gene is associated with autosomal dominant atrial septal defects (ASD) (MedGen UID: 412580), hypertrophic cardiomyopathy (HCM) (MedGen UID: 436962), dilated cardiomyopathy (DCM) (MedGen UID: 462031) and left ventricular noncompaction (LVNC) (MedGen UID: 349005).

Synonym(s): ACT; ACTG; BRWS2; DFNA20; DFNA26; HEL-176

The ACTG1 gene is associated with autosomal dominant deafness (MedGen UID: 346852) and Baraitser-Winter syndrome (MedGen UID: 482865).

The ACTN2 gene is associated with autosomal dominant dilated cardiomyopathy (DCM) with or without left ventricular noncompaction (LVNC) (MedGen UID: 393713) and hypertrophic cardiomyopathy (HCM) (MedGen UID: 183649).

Synonym(s): AMPS; ASASE; ASL

The ADSL gene is associated with autosomal recessive adenylosuccinate lyase (ADSL) deficiency (MedGen UID: 78641).

AGL
Synonym(s): GDE

The AGL gene is associated with autosomal recessive glycogen storage disease type III (GSD III) (MedGen UID: 6641).

The AGRN gene is associated with autosomal recessive congenital myasthenic syndrome 8 (CMS8) (MedGen UID: 815069).

Synonym(s): NAMSD; PDCD8

The AIFM1 gene is associated with X-linked Charcot-Marie-Tooth disease type 4 (CMTX4), also known as Chowchock syndrome (MedGen UID: 162891) and X-linked combined oxidative phosphorylation deficiency 6 (COXPD6) (OMIM: 300816).

Synonym(s): ADCL3; ARCL3A; GSAS; P5CS; PYCS; SPG9A; SPG9B

The ALDH18A1 gene is associated with autosomal dominant and recessive forms of cutis laxa (ADCL3 and ARCL3A, respectively) (MedGen UID: 851795, 82794) and spastic paraplegia (SPG9A and SPG9B, respectively) (MedGen UID: 322007, 851785). The ALDH18A1 gene is also associated with autosomal recessive pyrroline-5-carboxylate synthase (P5CS) deficiency (PMID: 11092761).

Synonym(s): Mitochondrial succinate semialdehyde dehydrogenase; NAD(+)-dependent succinic semialdehyde dehydrogenase; SSADH; SSDH

The ALDH5A1 gene is associated with autosomal recessive succinic semialdehyde dehydrogenase (SSADH) deficiency (MedGen UID: 124340).

Synonym(s): ATQ1; EPD; PDE

The ALDH7A1 gene is associated with autosomal recessive pyridoxine-dependent epilepsy (MedGen UID: 340341).

Synonym(s): CDG1S; CXorf45; EIEE36; GLT28D1; MDS031; TDRD13; YGL047W

The ALG13 gene is associated with the X-linked congenital disorder of glycosylation ALG13-CDG (CDG-Is) (MedGen UID 763818).

Synonym(s): CMS15

The ALG14 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive congenital myasthenic syndrome 15 (CMS15) (MedGen UID: 830988).

Synonym(s): CDGIi; CMS14; CMSTA3; FLJ14511; hALPG2; NET38

The ALG2 gene is associated with autosomal recessive congenital myasthenic syndrome 14 (CMS14) (MedGen UID: 831266). Additionally, the ALG2 gene has preliminary evidence supporting a correlation with autosomal recessive ALG2-congenital disorder of glycosylation (CDG-Ii).

Synonym(s): ALSS

The ALMS1 gene is associated with autosomal recessive Alstrom syndrome (MedGen UID: 78675).

Synonym(s): ALS2CR6; ALSJ; IAHSP; PLSJ

The ALS2 gene is associated with a spectrum of autosomal recessive conditions: infantile-onset ascending hereditary spastic paraplegia (IAHSP) (MedGen UID: 335467), juvenile primary lateral sclerosis (JPLS) (MedGen UID: 342870), and juvenile amyotrophic lateral sclerosis 2 (ALS2) (MedGen UID: 349246).

The AMPD2 gene is associated with autosomal recessive pontocerebellar hypoplasia, type 9 (PCH9) (MedGen UID: 799238). Additionally, the AMPD2 gene has preliminary evidence supporting a correlation with spastic paraplegia 63 (SPG63) (PMID: 24482476).

AMT
Synonym(s): GCE; GCST; GCVT; NKH

The AMT gene is associated with autosomal recessive glycine encephalopathy (MedGen UID: 155625).

The ANKRD1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 2880) and hypertrophic cardiomyopathy (HCM) (PMID: 19608031).

Synonym(s): C11orf25; TMEM16C

The ANO3 gene is associated with autosomal dominant dystonia 24 (DYT24) (MedGen UID: 767288).

Synonym(s): GDD1; LGMD2L; TMEM16E

The ANO5 gene is associated with autosomal recessive limb-girdle muscular dystrophy type 2L (LGDM2L) (MedGen UID: 370102) and Miyoshi muscular dystrophy 3 (MMD3) (MedGen UID: 413750). It is also associated with autosomal dominant gnathodiaphyseal dysplasia (GDD) (MedGen UID: 331575).

Synonym(s): SPG47

The AP4B1 gene is associated with autosomal recessive hereditary spastic paraplegia 47 (SPG47) (MedGen UID: 481368).

The AP4E1 gene is associated with autosomal recessive hereditary spastic paraplegia 51 (SPG51) (MedGen UID: 462406).

The AP4M1 gene is associated with autosomal recessive hereditary spastic paraplegia 50 (SPG50) (MedGen UID: 442869).

The AP4S1 gene is associated with autosomal recessive hereditary spastic paraplegia 52 (SPG52) (MedGen UID: 481373).

Synonym(s): KIAA0415

The AP5Z1 gene is associated with autosomal recessive hereditary spastic paraplegia 48 (SPG48) (MedGen UID: 462251).

APP
Synonym(s): AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2

The APP gene is associated with autosomal dominant Alzheimer’s disease type 1 (AD1) (MedGen UID: 1853) and APP-related cerebral amyloid angiopathy (CAA) (MedGen UID: 414044).

Synonym(s): ARGEF15; E5; Ephexin5; Vsm-RhoGEF

The ARHGEF15 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant early infantile epileptic encephalopathy (PMID: 23647072).

Synonym(s): COLLYBISTIN; EIEE8; HPEM-2; PEM-2; PEM2

The ARHGEF9 gene is associated with X-linked recessive hereditary hyperekplexia / early infantile epileptic encephalopathy 8 (EIEE8) (MedGen UID: 375581).

The ARL6IP1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive hereditary spastic paraplegia (PMID: 24482476).

The ARSI gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with hereditary spastic paraplegia (PMID: 24482476).

ARX
Synonym(s): CT121; EIEE1; ISSX; MRX29; MRX32; MRX33; MRX36; MRX38; MRX43; MRX54; MRX76; MRX87; MRXS1; PRTS

The ARX gene is associated with X-linked recessive early infantile epileptic encephalopathy (MedGen UID: 483052), or West syndrome, and X-linked lissencephaly with ambiguous genitalia (XLAG) (MedGen UID: 375832).

Synonym(s): AD-FSP; atlastin; FSP1

The ATL1 gene is associated with autosomal dominant hereditary spastic paraplegia type 3A (SPG3A) (MedGen UID: 419393) and hereditary sensory neuropathy type 1D (HSN1D) (MedGen UID: 462322).

The ATL3 gene is associated with autosomal dominant hereditary sensory neuropathy type 1F (HSN1F) (MedGen UID: 816524).

Synonym(s): CLN12; HSA9947; KRPPD; PARK9

The ATP13A2 gene is associated with autosomal recessive Kufor-Rakeb syndrome (KRS) (MedGen UID: 338281), also known as Parkinson’s disease 9 (PARK9). Additionally, the ATP13A2 gene has preliminary evidence supporting a correlation with autosomal recessive hereditary spastic paraplegia (MedGen UID:909889) and neuronal ceroid lipofuscinoses (PMID: 22388936).

Synonym(s): FHM2; MHP2

The ATP1A2 gene is associated with autosomal dominant familial hemiplegic migraine (MedGen UID: 355962).

Synonym(s): DYT12

The ATP1A3 gene is associated with autosomal dominant dystonia 12 (DYT12) (MedGen UID: 358384), cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss (CAPOS) syndrome (MedGen UID: 318633), and alternating hemiplegia of childhood (AHC) (MedGen UID: 766702).

The ATP2A1 gene is associated with autosomal recessive Brody myopathy (MedGen UID: 371441).

Synonym(s): APT6M8-9; ATP6IP2; ATP6M8-9; ELDF10; HT028; M8-9; MRXE; MRXSH; MSTP009; PRR; RENR; XMRE; XPDS

The ATP6AP2 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant X-linked intellectual disability with epilepsy (PMID: 15746149).

Synonym(s): DSMAX; MK; MNK; SMAX3

The ATP7A gene is associated with X-linked Menkes disease (MedGen UID: 44030), occipital horn syndrome (OHS) (MedGen UID: 82793) and distal hereditary motor neuropathy (HMN) (MedGen UID: 335168).

Synonym(s): ATR2; JMS; MRX52; MRXHF1; RAD54; RAD54L; SFM1; SHS; XH2; XNP; ZNF-HX

The ATRX gene is associated with Alpha-thalassemia X-linked intellectual disability (ATRX) syndrome (MedGen UID: 337145).

B
Synonym(s): B3GalNAc-T2; MDDGA11

The B3GALNT2 gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A11 (MDDGA11) (MedGen UID: 767552).

Synonym(s): GALGT; GalNAc-T; GALNACT; SPG26

The B4GALNT1 gene is associated with autosomal recessive hereditary spastic paraplegia 26 (SPG26) (PMID: 23746551).

Synonym(s): B3GN-T1; B3GNT1; B3GNT6; BETA3GNTI; iGAT; iGNT; MDDGA13

The B4GAT1 gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A13 (MDDGA13) (MedGen UID: 815372).

The BAG3 gene is associated with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 462643) and myofibrillar myopathy 6 (MFM6) (MedGen UID: 414119).

The BICD2 gene is associated with autosomal dominant spinal muscular atrophy, lower extremity predominant 2 (SMALED2) (MedGen UID: 815379).

Synonym(s): AMPHL

The BIN1 gene is associated with autosomal recessive centronuclear myopathy 2 (CNM2) (MedGen UID: 98049). Dominant inheritance has also been reported (PMID: 25260562).

Synonym(s): BAAT1; C7orf27; RMFSL

The BRAT1 gene is associated with autosomal recessive neonatal-lethal rigidity and multifocal seizure syndrome (RFMSL) (MedGen UID: 482659).

Synonym(s): GNG3LG; SPG17

The BSCL2 gene is associated with a spectrum of autosomal dominant neurological conditions, including Charcot-Marie-Tooth disease type 2 (CMT2) (PMID: 15732094), distal hereditary motor neuropathy type 5 (HMN5) (MedGen UID: 318838), and spastic paraplegia 17 (SPG17), also known as Silver syndrome (MedGen UID: 442302). It is also associated with autosomal recessive congenital generalized lipodystrophy, type 2 (CGL2) (MedGen UID: 318593).

C
Synonym(s): C10; GRCC10

The C12orf57 gene is associated with autosomal recessive Temtamy syndrome (MedGen UID: 347474).

The C12orf65 gene is associated with autosomal recessive Hereditary spastic paraplegia 55 (SPG55) (PMID: 23188110, 24080142) and autosomal recessive Combined oxidative phosphorylation deficiency 7 (COXPD7) (MedGen UID: 462151).

Synonym(s): NBIA3; NBIA4; SPG43

The C19ORF12 gene is associated with autosomal recessive neurodegeneration with brain iron accumulation 4(NBIA4) (MedGen UID: 482001). Additionally, the C19ORF12 gene has preliminary evidence supporting a correlation with autosomal recessive hereditary spastic paraplegia 43 (SPG43) (MedGen UID: 760531).

Synonym(s): APCA; BI; CACNL1A4; CAV2.1; EA2; FHM; HPCA; MHP; MHP1; SCA6

The CACNA1A gene is associated with CACNA1A-related conditions, which include autosomal dominant episodic ataxia type 2 (EA2) (MedGen UID: 314039), familial hemiplegic migraine type 1 (FHM1) (MedGen UID: 331389), and spinocerebellar ataxia 6 (SCA6) (MedGen UID: 148458).

Synonym(s): CACNL1A1; CCHL1A1

The CACNA1C gene is associated with autosomal dominant Timothy syndrome, also known as long QT syndrome (LQTS) type 8 (MedGen UID: 331395), Brugada syndrome (BrS) (MedGen UID: 395633), and short QT syndrome (SQTS) (MedGen UID: 378835).

Synonym(s): CACNA1HB; Cav3.2; ECA6; EIG6; HALD4

The CACNA1H gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant generalized epilepsy syndromes (PMID: 12891677, 15048902 , 17696120).

Synonym(s): CACNL1A3; HOKPP; MHS5

The CACNA1S gene is associated with autosomal dominant malignant hyperthermia susceptibility (MHS) (MedGen UID: 418958) and autosomal dominant hypokalemic periodic paralysis (HOKPP) (MedGen UID: 468371).

Synonym(s): CACNA2D

The CACNA2D2 gene is associated with autosomal recessive early infantile epileptic encephalopathy (PMID: 24358150, 23339110).

Synonym(s): CAB4; CACNLB4; EA5; EIG9; EJM; EJM4; EJM6

The CACNB4 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant idiopathic generalized epilepsy (PMID: 10762541).

The CALR3 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 462616).

Synonym(s): LGMD2; LGMD2A

The CAPN3 gene is associated with autosomal recessive limb-girdle muscular dystrophy type 2A (LGMD2A) (MedGen UID: 358391).

Synonym(s): COXPD27; cysRS

The CARS2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive combined oxidative phosphorylation deficiency 27 (PMID: 25787132, 25361775).

Synonym(s): CAGH39; CAMGUK; CMG; FGS4; LIN2; MICPCH; MRXSNA; TNRC8

The CASK gene is associated with X-linked intellectual disability (ID) (MedGen UID: 411367) and intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH) (MedGen UID: 437070).

Synonym(s): CAR; EIG8; FHH; FIH; GPRC2A; HHC; HHC1; HYPOC1; NSHPT; PCAR1

The CASR gene is associated with autosomal dominant familial isolated hyperparathyroidism (FIHP) (PMID: 14985373), autosomal dominant hypocalcemia (ADH) (MedGen UID: 87438), benign familial hypocalciuric hypercalcemia (BFHH) (MedGen UID: 369200), and autosomal recessive neonatal severe hyperparathyroidism (NSHPT) (MedGen UID: 331326). Additionally, there is preliminary evidence supporting a correlation with autosomal dominant idiopathic generalized epilepsy (PMID: 18756473) and chronic pancreatitis (PMID: 14641934, 16497624).

The CAV3 gene is associated with autosomal dominant long QT syndrome type 9 (LQT9) (MedGen UID: 395635) and hypertrophic cardiomyopathy (HCM) (MedGen UID: 501195). It is also associated with a spectrum of neuromuscular conditions including autosomal dominant hyperCKemia (MedGen UID: 69128) and distal myopathy (MedGen UID: 833809), and autosomal dominant and recessive limb-girdle muscular dystrophy type 1C (LGMD1C) (MedGen UID: 371358) and rippling muscle disease (MedGen UID: 342944), collectively known as the caveolinopathies (MedGen UID: 433151).

CBL
Synonym(s): C-CBL; CBL2; FRA11B; NSLL; RNF55

The CBL gene is associated with autosomal dominant Noonan-like syndrome with or without juvenile myelomonocytic leukemia (MedGen UID 462153).

Synonym(s): C16orf25

The CCDC78 gene is associated with autosomal dominant centronuclear myopathy 4 (CNM4) (MedGen UID: 766623).

Synonym(s): C7orf22; OSM; PP10187

The CCM2 gene is associated with autosomal dominant cerebral cavernous malformations (CCM) (MedGen UID: 400438).

The CCT5 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive hereditary sensory neuropathy with spastic paraplegia (HSP) (MedGen UID: 342492).

Synonym(s): CFAP247; EIEE2; ISSX; STK9

The CDKL5 gene is associated with X-linked dominant early infantile epileptic encephalopathy/West syndrome (MedGen UID: 326463), atypical Rett syndrome (PMID: 16015284, 15689447), and Angelman-like syndrome (MedGen UID: 472054).

Synonym(s): CDO; CDON1; HPE11; ORCAM

The CDON gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant holoprosencephaly (HPE) (PMID: 21802063).

Synonym(s): EPM8; LAG1; LASS1; UOG1

The CERS1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive progressive myoclonic epilepsy 8 (EPM8) (PMID: 24782409).

The CFL2 gene is associated with autosomal recessive nemaline myopathy 7 (NEM7) (MedGen UID: 343979).

The CHAT gene is associated with autosomal recessive congenital myasthenic syndrome 6 (CMS6) (MedGen UID: 140751).

Synonym(s): C22orf16; FTDALS2; IMMD; N27C7-4; SMAJ

The CHCHD10 gene is associated with autosomal dominant frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (FTDALS2) (MedGen UID: 797270), spinal muscular atrophy, Jokela type (SMAJ) (MedGen UID: 767312), and isolated mitochondrial myopathy (IMMD) (MedGen UID: 830724).

The CHCHD2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant Parkinson’s disease 22 (PARK22) (PMID: 25662902, 26067110).

Synonym(s): EEOC

The CHD2 gene is associated with autosomal dominant childhood-onset epileptic encephalopathy (MedGen UID: 815608).

Synonym(s): CRG; HH5; IS3; KAL5

The CHD7 gene is associated with autosomal dominant CHARGE syndrome (MedGen UID: 75567).

Synonym(s): CHKL

The CHKB gene is associated with autosomal recessive congenital muscular dystrophy, megaconial type (MDCMC) (MedGen UID: 355943).

Synonym(s): ALS17; CHMP2.5; DMT1; VPS2-2; VPS2B

The CHMP2B gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant chromosome 3-linked frontotemporal dementia (FTD3) (MedGen UID: 318833) and amyotrophic lateral sclerosis 17 (ALS17) (MedGen UID: 373010; PMID: 20352044, 16807408).

The CHRM2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (PMID: 18451336, 23743182).

Synonym(s): CHRNA

The CHRNA1 gene is associated with autosomal recessive and dominant forms of congenital myasthenic syndrome (CMS) (MedGen UIDs: 373259, 199759) and autosomal recessive fetal akinesia deformation sequence (FADS) (MedGen UID: 381473).

The CHRNA2 gene is associated with autosomal dominant nocturnal frontal lobe epilepsy (MedGen UID: 332082).

Synonym(s): BFNC; EBN; EBN1; NACHR; NACHRA4; NACRA4

The CHRNA4 gene is associated with autosomal dominant nocturnal frontal lobe epilepsy (MedGen UID: 324932).

Synonym(s): CHRNB

The CHRNB1 gene is associated with autosomal recessive and dominant forms of congenital myasthenic syndrome (CMS) (MedGen UIDs: 833647, 833664, 373251).

Synonym(s): EFNL3; nAChRB2

The CHRNB2 gene is associated with autosomal dominant nocturnal frontal lobe epilepsy (MedGen UID: 344263).

Synonym(s): ACHRD

The CHRND gene is associated with autosomal recessive and dominant forms of congenital myasthenic syndrome (CMS) (MedGen UIDs: 833694, 833685, 833675) and autosomal recessive fetal akinesia deformation sequence (FADS) (MedGen UID: 381473).

The CHRNE gene is associated with autosomal recessive and dominant forms of congenital myasthenic syndrome (CMS) (MedGen UIDs: 373251, 344169, 833673).

The CIZ1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dystonia 23 (PMID: 22447717).

The CLCN1 gene is associated with autosomal dominant and recessive myotonia congenita (MedGen UID: 422446, 155852).

Synonym(s): ClC-4; ClC-4A; CLC4; MRX15; MRX49

The CLCN4 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with X-linked early infantile epileptic encephalopathy (PMID: 23647072) and X-linked intellectual disability (PMID: 25644381).

Synonym(s): CLN2; GIG1; LPIC; SCAR7; TPP-1

The CLN2 gene (also known as TPP1) is associated with autosomal recessive neuronal ceroid lipofuscinosis type 2 (MedGen UID: 406281).

Synonym(s): BTN1; BTS; JNCL

The CLN3 gene is associated with autosomal recessive neuronal ceroid lipofuscinosis type 3 (CLN3) (MedGen UID: 155549).

Synonym(s): NCL

The CLN5 gene is associated with autosomal recessive neuronal ceroid lipofuscinosis type 5 (CLN5) (MedGen UID: 376792).

Synonym(s): CLN4A; HsT18960; nclf

The CLN6 gene is associated with autosomal recessive neuronal ceroid lipofuscinosis type 6 (CLN6) (MedGen UID: 356494).

Synonym(s): C8orf61; EPMR

The CLN8 gene is associated with autosomal recessive neuronal ceroid lipofuscinosis type 8 (CLN8) (MedGen UID: 374004).

The CNTN1 gene is associated with autosomal recessive Compton-North congenital myopathy (MYPCN) (MedGen UID: 393406).

Synonym(s): AXT; FAME5; TAG-1; TAX; TAX1

The CNTN2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive epilepsy (PMID: 23518707).

Synonym(s): AUTS15; CASPR2; CDFE; NRXN4; PTHSL1

The CNTNAP2 gene is associated with autosomal recessive intellectual disability disorders: cortical dysplasia-focal epilepsy syndrome (CDFES) (MedGen UID: 355859) and Pitt-Hopkins-like syndrome (PMID: 19896112).

Synonym(s): DPCK; NBIA6; NBP; pOV-2; PPAT; UKR1

The COASY gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive neurodegeneration with brain iron accumulation 6 (NBIA6) (MedGen UID: 816560).

The COL12A1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant Bethlem myopathy and autosomal recessive Ullrich congenital muscular dystrophy (PMID: 24334769, 24334604).

The COL6A1 gene is associated with autosomal dominant and recessive Bethlem myopathy 1 (BTHLM1) (MedGen UID: 331805) and Ullrich congenital muscular dystrophy 1 (UCMD1) (MedGen UID: 98046), collectively known as type VI collagenopathies (MedGen UID: 468393).

The COL6A2 gene is associated with autosomal dominant and recessive Bethlem myopathy 1 (BTHLM1) (MedGen UID: 331805) and Ullrich congenital muscular dystrophy 1 (UCMD1) (MedGen UID: 98046), collectively known as type VI collagenopathies (MedGen UID: 468393). Other COL6A2-related disorders have also been reported (OMIM: 120240).

The COL6A3 gene is associated with autosomal dominant and recessive Bethlem myopathy 1 (BTHLM1) (MedGen UID: 331805) and Ullrich congenital muscular dystrophy 1 (UCMD1) (MedGen UID: 98046), collectively known as type VI collagenopathies (MedGen UID: 468393). Other COL6A3-related disorders have also been reported (OMIM: 120250).

The COLQ gene is associated with autosomal recessive congenital myasthenic syndrome 5 (CMS5) (MedGen UID: 400481).

Synonym(s): CGI-92; COQ10D7

The COQ4 gene is associated with autosomal recessive primary coenzyme Q10 deficiency (MedGen UID: 833081). Additionally, the COQ4 gene has preliminary evidence supporting a correlation with autosomal recessive early infantile epileptic encephalopathy (EIEE) (PMID: 26795593).

CP
Synonym(s): CP-2

The CP gene is associated with autosomal recessive ceruloplasmin deficiency (Med Gen UID: 168057).

Synonym(s): CPAH; ETL5; FEB11

The CPA6 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant familial temporal lobe epilepsy 5 (PMID: 21922598, 25875328, 26648591, 23105115) and autosomal recessive familial febrile seizures 11 (PMID: 21922598, 23105115).

The CPT1C gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant spastic paraplegia 73 (SPG73) (MedGen UID: 833082).

Synonym(s): CPT1; CPTASE; IIAE4

The CPTII gene is associated with autosomal recessive carnitine palmitoyltransferase II (CPTII or CPT2) deficiency (MedGen UID: 371584, 322211, 318896).

Synonym(s): CMD1II; CRYA2; CTPP2; CTRCT16; HEL-S-101; HSPB5; MFM2

The CRYAB gene is associated with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 767563) and cataracts (MedGen UID: 462415). It is also associated with autosomal dominant and recessive myofibrillar myopathy 2 (MFM2) (MedGen UID: 324735).

The CSRP3 gene is associated with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 429755) and dilated cardiomyopathy (DCM) (MedGen UID: 334498).

Synonym(s): CPI-B; CST6; EPM1; EPM1A; PME; STFB; ULD

The CSTB gene is associated with autosomal recessive Unverricht-Lundborg syndrome (MedGen UID: 155923), a subtype of progressive myoclonic epilepsy.

The CTF1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (PMID: 11058912).

The CTNNA3 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) (MedGen UID: 816468).

Synonym(s): CLN10; CPSD; HEL-S-130P

The CTSD gene is associated with autosomal recessive neuronal ceroid lipofuscinosis type 10 (CLN10) (MedGen UID: 350481).

The CYP2U1 gene is associated with autosomal recessive hereditary spastic paraplegia 56 (SPG56) (MedGen UID: 761343).

Synonym(s): SPG5A

The CYP7B1 gene is associated with autosomal recessive hereditary spastic paraplegia type 5A (SPG5A) (MedGen UID: 376521) and autosomal recessive congenital bile acid synthesis defect type 3 (CBAS3) (MedGenUID: 462497).

D
Synonym(s): DAG

The DAG1 gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A9 (MDDGA9) (MedGen UID: 851332) and type C9 (MDDGC9) (MedGen UID: 462534).

Synonym(s): C2orf37

The DCAF17 gene is associated with autosomal recessive Woodhouse-Sakati syndrome (WSS) (MedGen UID: 83337).

Synonym(s): DAP-150; DP-150; P135

The DCTN1 gene is associated with autosomal dominant Perry syndrome (MedGen UID: 357007), distal hereditary motor neuropathy type VIIB (HMN7B) (MedGen UID: 375157), and amyotrophic lateral sclerosis 1 (ALS1) (MedGen UID: 400169).

Synonym(s): SPG28

The DDHD1 gene is associated with autosomal recessive hereditary spastic paraplegia 28 (SPG28) (MedGen UID: 332174)

Synonym(s): KIAA0725; SPG54

The DDHD2 gene is associated with autosomal recessive hereditary spastic paraplegia 54 (SPG54) (MedGen UID: 761341).

Synonym(s): DEP.5; FFEVF

The DEPDC5 gene is associated with autosomal dominant familial focal epilepsy with variable foci (FFEVF) (MedGen UID: 348951) and autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) (MedGEN UID: 432738).

DES

The DES gene is associated with autosomal dominant and recessive myofibrillar myopathy 1 (MFM1) (MedGen UID: 330449). It is also associated with autosomal recessive limb-girdle muscular dystrophy type 2R (LGMD2R)(MedGen UID: 815467) and autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 387998).

Synonym(s): DFNA1; DIA1; DRF1; hDIA1; LFHL1; SCBMS

The DIAPH1 gene is associated with autosomal recessive seizures, cortical blindness, and microcephaly syndrome (SCBMS) (MedGen UID: 851846). Additionally, the DIAPH1 gene has preliminary evidence supporting a correlation with autosomal dominant deafness 1 (DFNA1) (PMID: 9360932, 25342930, 22938506; MedGen UID: 343767).

DMD

The DMD gene is associated with X-linked Duchenne muscular dystrophy (DMD) (MedGen UID: 3925), Becker muscular dystrophy (BMD) (MedGen UID: 182959), and dilated cardiomyopathy (DCM) (MedGen UID: 777148).

The DNAJB2 gene is associated with autosomal recessive distal hereditary motor neuropathy, also known as distal spinal muscular atrophy 5 (DSMA5) (MedGen UID: 766903) and Charcot-Marie-Tooth disease type 2T (CMT2T) (MedGen UID: 831274).

Synonym(s): LGMD1D

The DNAJB6 gene is associated with autosomal dominant limb-girdle muscular dystrophy type 1E (LGMD1E), also known as LGMD1D (MedGen UID: 460114) and distal myopathy (PMID: 26205529).

Synonym(s): PAM18; TIM14; TIMM14

The DNAJC19 gene is associated with autosomal recessive 3-Methylglutaconic aciduria, type V (MedGen UID: 347542).

Synonym(s): CLN4; CLN4B; CSP; DNAJC5A; mir-941-2; mir-941-3; mir-941-4; mir-941-5; NCL

The DNAJC5 gene is associated with autosomal dominant neuronal ceroid lipofuscinosis type 4B (CLN4B) (MedGen UID: 320287).

The DNAJC6 gene is associated with autosomal recessive juvenile-onset Parkinson’s disease 19 (PARK19) (MedGen UID: 816141).

Synonym(s): DNM; EIEE31

The DNM1 gene is associated with autosomal dominant early infantile epileptic encephalopathy 31 (EIEE31) (MedGen UID: 833832).

The DNM2 gene is associated with autosomal dominant centronuclear myopathy (DNM2-CNM) (MedGen UID: 322437), dominant intermediate Charcot-Marie-Tooth disease type B (CMTDIB) (MedGen UID: 338346) and Charcot-Marie-Tooth disease type 2M (CMT2M) (OMIM: 606482). Additionally, the DNM2 gene has preliminary evidence supporting a correlation with autosomal recessive lethal congenital contracture syndrome (LCCS5) (MedGen UID: 344338).

The DNMT1 gene is associated with autosomal dominant hereditary sensory neuropathy type 1E (HSN1E) (MedGen UID: 481515) and cerebellar ataxia, deafness, and narcolepsy (ADCADN) (MedGen UID: 347726).

Synonym(s): EIEE23; ZIR2

The DOCK7 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive early infantile epileptic encephalopathy 23 (EIEE23) (PMID: 24814191).

Synonym(s): C4orf25

The DOK7 gene is associated with autosomal recessive congenital myasthenic syndrome 10 (CMS10) (MedGen UID: 376880) and fetal akinesia deformation sequence (FADS) (MedGen UID: 220903).

Synonym(s): CDG1M; DK; DK1; SEC59; TMEM15

The DOLK gene is associated with the autosomal recessive congenital disorder of glycosylation DOLK-CDG (CDG-Im) (MedGen UID 332072).

Synonym(s): ALG7; CDG-Ij; CDG1J; CMS13; CMSTA2; D11S366; DGPT; DPAGT; DPAGT2; G1PT; GPT; UAGT; UGAT

The DPAGT1 gene is associated with autosomal recessive DPAGT1-congenital disorder of glycosylation (CDG-Ij) (MedGen UID: 334113) and congenital myasthenic syndrome 13 (CMS13) (MedGen UID: 766559).

Synonym(s): CDGIE; MPDS

The DPM1 gene is associated with autosomal recessive DPM1-congenital disorder of glycosylation (CDG-Ie) (MedGen UID: 324784).

Synonym(s): CDG1U

The DPM2 gene is associated with autosomal recessive DPM2-congenital disorder of glycosylation (CDG-Iu) (MedGen UID: 767299).

Synonym(s): CDG1O

The DPM3 gene is associated with autosomal recessive DPM3-congenital disorder of glycosylation (CDG-Io) (MedGen UID: 414534).

The DRD2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant myoclonic dystonia (MedGen UID: 331778).

Synonym(s): DSC3

The DSC2 gene is associated with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) (MedGen UID: 351237) and autosomal recessive ARVC with palmoplantar keratoderma and woolly hair (OMIM: 125645).

The DSG2 gene is associated with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) (MedGen UID: 347543) and dilated cardiomyopathy (DCM) (MedGen UID: 414552).

DSP

The DSP gene is associated with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) (MedGen UID: 336069) and dilated cardiomyopathy (DCM) with woolly hair, keratoderma and tooth agenesis (MedGen UID: 808093), as well as autosomal recessive DCM with woolly hair and keratoderma (MedGen UID: 340124). Additional DSP-related conditions have been reported (OMIM: 125647).

DST

The DST gene is associated with autosomal recessive hereditary sensory and autonomic neuropathy type 6 (HSAN6) (MedGen UID: 761278) and epidermolysis bullosa simplex 2 (EBSB2) (MedGen UID: 815800).

The DTNA gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant left ventricular noncompaction (LVNC) (MedGen UID: 349005).

Synonym(s): CMT2O; DHC1; DHC1a; DNCH1; Dnchc1; DNCL; DNECL; DYHC; HL-3; p22; SMALED1

The DYNC1H1 gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2O (CMT2O) (MedGen UID: 481850), lower extremity predominant spinal muscular atrophy 1 (SMALED1) (MedGen UID: 322470) and intellectual disability (MedGen UID: 482832).

Synonym(s): DYRK; DYRK1; HP86; MNB; MNBH; MRD7

The DYRK1A gene is associated with autosomal dominant intellectual disability 7 (IDD7) (MedGen UID: 481469).

Synonym(s): LGMD2B

The DYSF gene is associated with autosomal recessive Miyoshi muscular dystrophy type 1 (MMD1) (MedGen UID: 338128) and limb-girdle muscular dystrophy type 2B (LGMD2B) (MedGen UID: 338149), collectively known as the dysferlinopathies (MedGen UID: 419874). Other DYSF-related conditions have also been reported (OMIM: 606768).

E
Synonym(s): EEF1AL; EF-1-alpha-2; EF1A; EIEE33; HS1; MRD38; STN; STNL

The EEF1A2 gene is associated with autosomal dominant early infantile epileptic encephalopathy 33 (EIEE33) (MedGen UID: 834052).

Synonym(s): dJ304B14.2; EJM1

The EFHC1 gene is associated with autosomal dominant juvenile myoclonic epilepsy (JME) (MedGen UID: 342587) and juvenile absence epilepsy (JAE) (MedGen UID: 4989).

Synonym(s): KROX20

The EGR2 gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 1D (CMT1D) (MedGen UID: 334709), and autosomal recessive Charcot-Marie-Tooth disease type 4E (CMT4E, also known as congenital hypomyelinating neuropathy) (MedGen UID: 97965).

Synonym(s): bA188C12.1; Eu-HMTase1; EUHMTASE1; FP13812; GLP; GLP1; KMT1D

The EHMT1 gene is associated with autosomal dominant Kleefstra syndrome (MedGen UID: 208639).

The ELAC2 gene is associated with autosomal recessive combined oxidative phosphorylation deficiency (MedGen UID: 322999).

EMD

The EMD gene is associated with X-linked Emery-Dreifuss muscular dystrophy (EDMD) (MedGen UID: 148284).

The ENTPD1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive spastic paraplegia 64 (SPG64) (PMID: 24482476).

Synonym(s): EPM2; MELF

The EPM2A gene is associated with autosomal recessive progressive myoclonus epilepsy, Lafora type (MedGen UID: 155631).

The ERLIN1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with hereditary spastic paraplegia (PMID: 24482476).

Synonym(s): C8orf2; Erlin-2; SPFH2; SPG18

The ERLIN2 gene is associated with autosomal recessive hereditary spastic paraplegia 18 (SPG18) (MedGen UID: 442343).

The EXOSC3 gene is associated with autosomal recessive pontocerebellar hypoplasia (PCH) type 1 (MedGen UID: 766363).

Synonym(s): CMD1J; DFNA10

The EYA4 gene is associated with autosomal dominant dilated cardiomyopathy (DCM) with hearing loss (MedGen UID: 343105). Additional EYA4-related conditions have been reported (OMIM: 603550).

F
Synonym(s): FAAH; FAH1; FAXDC1; SCS7; SPG35

The FA2H gene is associated with autosomal recessive hereditary spastic paraplegia 35 (SPG35) (MedGen UID: 777150).

The FAM134B gene is associated with autosomal recessive hereditary sensory and autonomic neuropathy type 2B (HSAN2B) (MedGen UID: 413474).

Synonym(s): COXPD14; FARS1; HSPC320; PheRS; SPG77

The FARS2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive combined oxidative phosphorylation deficiency (PMID: 22499341, 22833457, 25851414).

Synonym(s): FAS; OA-519; SDR27X1

The FASN gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant epileptic encephalopathy (PMID: 25262651).

The FBXO38 gene is associated with autosomal dominant distal hereditary motor neuropathy 2D (HMN2D) (MedGen UID: 777992).

Synonym(s): FBX7

The FBXO7 gene is associated with autosomal recessive Parkinson’s disease 15 (PARK15) (MedGen UID: 337969).

The FGD4 gene is associated with autosomal recessive Charcot-Marie-Tooth disease type 4H (CMT4H) (MedGen UID: 324487).

Synonym(s): FHL1A

The FHL1 gene is associated with X-linked Emery-Dreifuss muscular dystrophy type 6 (EDMD6) (MedGen UID: 395525), reducing body myopathies (RBM) (MedGen UIDs: 394710, 394714) and hypertrophic cardiomyopathy (PMID: 24114807). Other FHL1-related conditions have been reported (OMIM: 300163).

The FHL2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant hypertrophic cardiomyopathy (HCM) (PMID: 25358972).

Synonym(s): KIAA0274; SAC3

The FIG4 gene is associated with autosomal recessive Charcot-Marie-Tooth disease type 4J (CMT4J) (MedGen UID: 370808) and Yunis-Varon syndrome (MedGen UID: 341818). Additionally, the FIG4 gene has preliminary evidence supporting a correlation with autosomal dominant amyotrophic lateral sclerosis 11 (ALS11) (PMID: 19118816; MedGen UID: 393399).

The FKBP14 gene is associated with autosomal recessive Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss (EDSKMH) (MedGen UID: 482790).

Synonym(s): LGMD2I; MDC1C; MDDGA5; MDDGB5; MDDGC5

The FKRP gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A5 (MDDGA5) (MedGen UID:461763), type B5 (MDDGB5) (MedGen UID:335764), and type C5 (MDDGC5) (MedGen UID:339580), and dilated cardiomyopathy (DCM) (MedGen UID:2880).

Synonym(s): CMD1X; FCMD; LGMD2M; MDDGA4; MDDGB4; MDDGC4

The FKTN gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A4 (MDDGA4), also known as Fukuyama congenital muscular dystrophy (FCMD) (MedGen UID: 140820), type B4 (MDDGB4) (MedGen UID: 413465) and type C4 (MDDGC4) (MedGen UID: 370585), and dilated cardiomyopathy (DCM) (MedGen UID: 370583).

Synonym(s): FLN; FLN1; OPD1; OPD2

The FLNA gene is associated with X-linked Ehlers-Danlos syndrome (EDS) with periventricular heterotopia (MedGen UID: 375610) and cardiac vavlular dysplasia (MedGen UID: 78083). Other FLNA-related conditions have also been reported (OMIM: 300017).

Synonym(s): FLN2

The FLNC gene is associated with autosomal dominant myofibrillar myopathy 5 (MFM5) (MedGen UID: 372186), distal myopathy 4 (MPD4) (MedGen UID: 481352), and dilated cardiomyopathy (PMID: 25633252, 27908349). Additionally, the FLNC gene has preliminary evidence supporting a correlation with autosomal dominant hypertrophic cardiomyopathy (PMID: 25351925) and restrictive cardiomyopathy (PMID: 26666891).

The FLRT1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive peripheral neuropathy (PMID: 24482476).

Synonym(s): FBP; FOLR

The FOLR1 gene is associated with autosomal recessive cerebral folate deficiency (MedGen UID: 442763).

Synonym(s): BF1; BF2; FHKL3; FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C; HBF-1; HBF-2; HBF-3; HBF-G2; HBF2; HFK1; HFK2; HFK3; KHL2; QIN

The FOXG1 gene is associated with autosomal dominant congenital / atypical Rett syndrome (MedGen UID: 462055).

Synonym(s): FAST-1; FAST1

FOXH1 is associated with autosomal dominant heterotaxy, which includes congenital heart disease such as tetralogy of Fallot, as well as extracardiac laterality defects (PMID: 18538293). Additionally, the FOXH1 gene has preliminary evidence supporting a correlation with autosomal dominant holoprosencephaly (MedGen UID: 38214; PMID: 18538293).

Synonym(s): C9orf4; CG-6; CG6; EIEE37

The FRRS1L gene is associated with autosomal recessive early infantile epileptic encephalopathy 37 (EIEE37) (MedGen UID: 881218).

FTL
Synonym(s): LFTD; NBIA3

The FTL gene is associated with autosomal dominant neurodegeneration with brain iron accumulation 3 (NBIA3) (MedGen UID: 381211) and hereditary hyperferritinemia-cataract syndrome (HHCS) (MedGen UID: 318812). Additionally, the FTL gene has preliminary evidence supporting a correlation with L-ferritin deficiency (PMID: 23940258, 15173247).

Synonym(s): FUCA

The FUCA1 gene is associated with autosomal recessive fucosidosis (MedGen UID: 5288)

FUS
Synonym(s): ALS6; ETM4; FUS1; HNRNPP2; POMP75; TLS

The FUS gene is associated with autosomal dominant amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) (MedGen UID: 374989). Additionally, the FUS gene has preliminary evidence supporting an association with autosomal dominant hereditary essential tremor 4 (ETM4) (MedGen UID: 761337).

G
GAA
Synonym(s): LYAG

The GAA gene is associated with autosomal recessive glycogen storage disease type II (GSDII), also known as Pompe disease (MedGen UID: 5340).

Synonym(s): GABABR2; GPR51; GPRC3B; HG20; HRIHFB2099

The GABBR2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant epileptic encephalopathy (PMID: 25262651).

Synonym(s): ECA4; EIEE19; EJM; EJM5

The GABRA1 gene is associated with autosomal dominant early infantile epileptic encephalopathy (MedGen UID: 483052), childhood absence epilepsy (MedGen UID: 369671), and juvenile myoclonic epilepsy (MedGen UID: 442345).

The GABRA6 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant childhood absence epilepsy (PMID: 19429026, 21930603).

The GABRB2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant intellectual disability and epilepsy (PMID: 25124326).

Synonym(s): ECA5

The GABRB3 gene is associated with autosomal dominant childhood absence epilepsy (CAE), a type of autosomal dominant idiopathic generalized epilepsy (MedGen UID: 393654).

Synonym(s): EIG10; EJM7; GEFSP5

The GABRD gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant susceptibility to generalized epilepsy with febrile seizures plus, type 5 (GEFSP5), idiopathic generalized epilepsy 10 (EIG10), and susceptibility to juvenile myoclonic epilepsy 7 (EJM7) (PMID: 15115768, 16023832).

Synonym(s): CAE2; ECA2; GEFSP3

The GABRG2 gene is associated with autosomal dominant childhood absence epilepsy (CAE) (MedGen UID: 334707), generalized epilepsy with febrile seizures plus, and familial febrile seizures (MedGen UID: 370755).

GAL
Synonym(s): ETL8; GAL-GMAP; GALN; GLNN; GMAP

The GAL gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with familial temporal lobe epilepsy 8 (ETL8) (PMID: 25691535).

Synonym(s): CCDS2; HEL-S-20; PIG2; TP53I2

The GAMT gene is associated with autosomal recessive cerebral creatine deficiency syndrome (MedGen UID: 154356).

GAN

The GAN gene is associated with autosomal recessive giant axonal neuropathy 1 (GAN1) (MedGen UID: 376775).

Synonym(s): CMT2D

The GARS gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2D (CMT2D) (MedGen UID: 316946) and distal hereditary motor neuropathy 5 (HMN5) (MedGen UID: 318838), collectively referred to as GARS-associated axonal neuropathies (MedGen UID: 468432).

Synonym(s): ASD2; TACHD; TOF; VSD1

The GATA4 gene is associated with a spectrum of congenital heart defects including autosomal dominant tetralogy of Fallot (MedGen UID: 21498), ventricular septal defects (MedGen UID: 482407), atrial septal defects (MedGen UID: 334249), atrioventricular septal defects (MedGen UID: 482411). Additionally, the GATA4 gene has preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (PMID: 24041700).

The GATA6 gene has preliminary evidence supporting a correlation with autosomal dominant tetralogy of Fallot (MedGen UID: 21498), atrial septal defects (MedGen UID: 482573), atrioventricular septal defects (MedGen UID: 482569), persistent truncus arteriosus (MIM: 217095), congenital heart defects with pancreatic agenesis (MIM: 600001), and dilated cardiomyopathy (DCM) (PMID: 25119427).

The GATAD1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive dilated cardiomyopathy (DCM) (MedGen UID: 766323).

Synonym(s): AGAT; AT; CCDS3; Glycine Amidinotransferase; Glycine Amidinotransferase (L-Arginine:Glycine Amidinotransferase; L-Arginine:Glycine Amidinotransferase; Mitochondrial; Transamidinase

The GATM gene is associated with autosomal recessive cerebral creatine deficiency syndrome (MedGen UID: 436367).

Synonym(s): SPG46

The GBA2 gene is associated with autosomal recessive hereditary spastic paraplegia 46 (SPG46) (MedGen UID: 473687).

Synonym(s): DYT14; DYT5; DYT5a; GCH; GTP-CH-1; GTPCH1; HPABH4B

The GCH1 gene is associated with autosomal dominant dopa-responsive dystonia (DRD) (MedGen UID: 342121). It is also associated with autosomal recessive GTP cyclohydrolase deficiency (MedGen UID: 75683).

Synonym(s): GCE; NKH

The GCSH gene is associated with autosomal recessive glycine encephalopathy (MedGen UID: 155625).

Synonym(s): CMT4A

The GDAP1 gene is associated with autosomal recessive and dominant forms of Charcot-Marie-Tooth disease (MedGen UID: 347821, 375064, 334012, 375113).

Synonym(s): CMS12; CMSTA1; GFA; GFAT; GFAT 1; GFAT1; GFAT1m; GFPT; GFPT1L; MSLG

The GFPT1 gene is associated with autosomal recessive congenital myasthenic syndrome 12 (CMS12) (MedGen UID: 350478).

Synonym(s): CMTX; CMTX1

The GJB1 gene (also known as connexin 32, or Cx32) is associated with X-linked Charcot-Marie-Tooth disease type 1X (CMT1X) (MedGen UID: 98290).

Synonym(s): GJA12

The GJC2 gene is associated with autosomal recessive hereditary spastic paraplegia 44 (SPG44) (MedGen UID: 413042) and autosomal dominant primary lymphadema (MedGen UID: 462082).

GLA
Synonym(s): GALA

The GLA gene is associated with X-linked Fabry disease (MedGen UID: 8083).

Synonym(s): GCE; GCSP; HYGN1

The GLDC gene is associated with autosomal recessive glycine encephalopathy (MedGen UID: 155625).

Synonym(s): CJS; HPE9; PHS2; THP1; THP2

The GLI2 gene is associated with autosomal dominant holoprosencephaly (HPE) (MedGen UID: 324369) and pituitary abnormalities with or without additional features (MedGen UID: 786407).

Synonym(s): HKPX1; STHE

The GLRA1 gene is associated with autosomal dominant and autosomal recessive hyperekplexia 1 (HKPX1) (MedGen UID: 332019).

Synonym(s): MDDGA14; MDDGB14; MDDGC14

The GMPPB gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A14 (MDDGA14) (MedGen UID: 815546), type B14 (MDDGB14) (MedGen UID: 815551) and type C14 (MDDGC14) (MedGen UID: 811507). Additionally, the GMPPB gene has preliminary evidence supporting a correlation with autosomal recessive congenital myasthenic syndrome (CMS) (PMID: 26133662).

The GNAL gene is associated with autosomal dominant dystonia 25 (DYT25) (MedGen UID: 767361).

Synonym(s): EIEE17; G-ALPHA-o; GNAO; HLA-DQB1

The GNAO1 gene is associated with autosomal dominant early infantile epileptic encephalopathy (MedGen UID: 815936).

The GNB4 gene is associated with dominant intermediate Charcot-Marie-Tooth disease type F (CMTDIF) (MedGen UID: 767568).

GNE
Synonym(s): DMRV; GLCNE; IBM2; NM; Uae1

The GNE gene is associated with autosomal recessive GNE-related myopathy (MedGen UID: 322174) and autosomal dominant sialuria (MedGen UID: 137980).

Synonym(s): Bos1; EPM6; GS27

The GOSR2 gene is associated with autosomal recessive progressive myoclonic epilepsy (MedGen UID: 481257).

Synonym(s): GEPH; GPH; GPHRYN; HKPX1; MOCODC

The GPHN gene is associated with autosomal recessive molybdenum cofactor deficiency complementation group C (MOCODC) (MedGen UID: 340761). Additionally, the GPHN gene has preliminary evidence supporting a correlation with autosomal dominant early infantile epileptic encephalopathy (EIEE) (PMID: 26613940, 24561070).

Synonym(s): GluN1; MRD8; NMD-R1; NMDA1; NMDAR1; NR1

The GRIN1 gene is associated with autosomal dominant early infantile epileptic encephalopathy (PMID: 25864721, 23934111) and autosomal dominant intellectual disability (MedGen UID: 481912).

Synonym(s): EPND; FESD; GluN2A; LKS; NMDAR2A; NR2A

The GRIN2A gene is associated with autosomal dominant focal epilepsy with speech disorder, with or without intellectual disability (MedGen UID: 322043).

Synonym(s): EIEE27; GluN2B; hNR3; MRD6; NMDAR2B; NR2B

The GRIN2B gene is associated with autosomal dominant early infantile epileptic encephalopathy (MedGen UID: 830511) and autosomal dominant intellectual disability (MedGen UID: 462761).

GRN
Synonym(s): CLN11; GEP; GP88; PCDGF; PEPI; PGRN

The GRN gene is associated with autosomal dominant GRN-related frontotemporal dementia (FTD-GRN) (MedGen UID: 375285) and autosomal recessive neuronal ceroid lipofuscinosis type 11 (CLN11) (MedGen UID: 761331).

H

The HARS gene is associated with autosomal dominant Charcot-Marie-Tooth disease, type 2W (CMT2W) (MedGen UID: 851839).

Synonym(s): BCNG-1; BCNG1; EIEE24; HAC-2

The HCN1 gene is associated with autosomal dominant early infantile epileptic encephalopathy (MedGen UID: 786443).

The HCN4 gene is associated with autosomal dominant left ventricular noncompaction (LVNC) (PMID: 25145517), Brugada syndrome (BrS) (MedGen UID: 413928), and sinus node dysfunction or bradycardia (MedGen UID: 320273).

The HINT1 gene is associated with autosomal recessive neuromyotonia and axonal neuropathy (NMAN) (MedGen UID: 449355).

Synonym(s): HNRNPA2; HNRNPB1; HNRPA2; HNRPA2B1; HNRPB1; IBMPFD2; RNPA2; SNRPB1

The HNRNPA2B1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 (IBMPFD2) (MedGen UID: 815798; PMID: 23455423).

The HNRNPDL gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant limb-girdle muscular dystrophy (LGMD) (PMID: 24647604).

Synonym(s): hnRNP U; HNRNPU-AS1; HNRPU; SAF-A; SAFA; U21.1

The HNRNPU gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant early infantile epileptic encephalopathy (PMID: 23934111, 24885232, 22975012, 22678713, 21800092) and autosomal dominant intellectual disability (PMID: 22678713, 25356899).

The HPCA gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive torsion dystonia 2 (DYT2) (MedGen UID: 346511).

The HSPB1 gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2F (CMT2F) (MedGen UID: 335784) and distal hereditary motor neuropathy 2B (HMN2B) (MedGen UID: 382017).

The HSPB3 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant distal hereditary motor neuropathy 2C (HMN2C) (MedGen UID: 461969).

The HSPB8 gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2L (CMT2L) (MedGen UID: 324826) and distal hereditary motor neuropathy 2A (HMN2A) (MedGen UID: 322471).

Synonym(s): SPG13

The HSPD1 gene is associated with autosomal dominant Hereditary spastic paraplegia 13 (SPG13) (MedGen UID: 344289) and autosomal recessive hypomyelinating leukodystrophy 4 (HLD4), also known as MitCHAP-60 disease (Medgen UID: 383026).

I
Synonym(s): C1orf69; MMDS3; SPG74

The IBA57 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive spastic paraplegia 74 (PMID: 25609768) and multiple mitochondrial dysfunctions syndrome 3 (PMID: 25971455, 23462291).

Synonym(s): HSPC039; MEDS; PRO2309

The IER3IP1 gene is associated with autosomal recessive microcephaly, epilepsy, and diabetes syndrome (MEDS) (MedGen UID: 481870).

The IGHMBP2 gene is associated with autosomal recessive distal hereditary motor neuropathy 6, also known as spinal muscular atrophy with respiratory distress 1 (SMARD1) (MedGen UID: 388083) and Charcot-Marie-Tooth disease type 2S (CMT2S) (MedGen UID: 830572).

Synonym(s): DYS

The IKBKAP gene is associated with autosomal recessive familial dysautonomia, also known as hereditary sensory and autonomic neuropathy type 3 (HSAN3) (MedGen UID: 41678).

ILK

The ILK gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (PMID: 17646580).

The INF2 gene is associated with autosomal dominant focal segmental glomerulosclerosis (FSGS) (MedGen UID 413315) and dominant intermediate Charcot-Marie-Tooth disease type E (CMT-DIE) (MedGen UID 482475).

Synonym(s): BRAG1; MRX1; MRX78

The IQSEC2 gene is associated with X-linked intellectual disability (MedGen UID: 444070).

Synonym(s): hCG_1745121; MDDGA7; MDDGC7; Nip

The ISPD gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A7 (MDDGA7) (MedGen UID: 766244) and type C7 (MDDGC7) (MedGen UID: 807556).

The ITGA7 gene is associated with autosomal recessive congenital muscular dystrophy due to integrin alpha-7 deficiency (MedGen UID: 413044).

Synonym(s): C20orf37; dJ794I6.3; EIEE35; HLC14-06-P; ITPase; My049; NTPase

The ITPA gene is associated with autosomal recessive inosine triphosphate pyrophosphohydrolase (ITPase) deficiency (MedGen UID: 333499).

J
Synonym(s): TRIP-8; TRIP8

The JMJD1C gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with Rett syndrome and intellectual disability (PMID: 26181491).

The JPH2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 462614).

JUP
Synonym(s): CTNNG

The JUP gene is associated with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) (MedGen UID: 409749) and autosomal recessive Naxos disease (MedGen UID: 321991).

K
Synonym(s): CENP-36; hMSL1v1; KDVS; KIAA1267; MSL1v1; NSL1

The KANSL1 gene is associated with autosomal dominant Koolen-de Vries syndrome (MedGen UID: 355853).

The KBTBD13 gene is associated with autosomal dominant nemaline myopathy 6 (NEM6) (MedGen UID: 373095).

Synonym(s): AEMK; EA1; HBK1; HUK1; KV1.1; MBK1; MK1; RBK1

The KCNA1 gene is associated with autosomal dominant episodic ataxia type 1 (EA1) (MedGen UID: 318554).

Synonym(s): EIEE32; HBK5; HK4; HUKIV; KV1.2; MK2; NGK1; RBK2

The KCNA2 gene is associated with autosomal dominant early infantile epileptic encephalopathy 32 (EIEE32) (MedGen UID: 833891).

Synonym(s): DRK1; Kv2.1

The KCNB1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant early infantile epileptic encephalopathy 26 (PMID: 25164438, 26648591).

Synonym(s): EPM7; KV3.1; KV4; NGK2

The KCNC1 gene is associated with autosomal dominant progressive myoclonic epilepsy 7 (PME7) (MedGen UID: 830625).

Synonym(s): KIAA1044; KV4.2; RK5

The KCND2 gene currently has no well-established disease association; however, there is preliminary evidence supporting correlation with epilepsy and J-wave syndrome (PMID: 24501278, 25214526, 16934482).

Synonym(s): ERG-1; ERG1; H-ERG; HERG; HERG1; Kv11.1; LQT2; SQT1

The KCNH2 gene is associated with autosomal dominant long QT syndrome (LQTS), type 2 (MedGen UID: 462293), short QT syndrome (SQTS) (MedGen UID: 355891) and Brugada syndrome (BrS) (MedGen UID: 222975).

Synonym(s): EAG2; H-EAG2; hEAG2; Kv10.2

The KCNH5 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant early infantile epileptic encephalopathy (PMID: 23647072).

Synonym(s): BIRK-10; KCNJ13-PEN; KIR1.2; KIR4.1; SESAME

The KCNJ10 gene is associated with autosomal recessive SeSAME syndrome (MedGen UID: 411243).

The KCNJ2 gene is associated with autosomal dominant Andersen-Tawil syndrome, also known as long QT syndrome (LQTS), type 7 (MedGen UID: 327586), short QT syndrome (SQTS) (MedGen UID: 400662), and catecholaminergic polymorphic ventricular tachycardia (CPVT) (PMID: 22589293). Additionally, the KCNJ2 gene has preliminary evidence supporting a correlation with autosomal dominant atrial fibrillation (MedGen UID: 462781).

Synonym(s): bA205K10.1; BKTM; hSlo; KCa1.1; MaxiK; mSLO1; SAKCA; SLO; SLO-ALPHA; SLO1

The KCNMA1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant generalized epilepsy and paroxysmal dyskinesia (PMID:15937479).

Synonym(s): BFNC; EBN; EBN1; ENB1; HNSPC; KCNA11; KV7.2

The KCNQ2 gene is associated with autosomal dominant benign familial neonatal seizures (MedGen UID: 342266) and early infantile epileptic encephalopathy (MedGen UID: 462336).

Synonym(s): BFNC2; EBN2; KV7.3

The KCNQ3 gene is associated with autosomal dominant benign familial neonatal seizures (MedGen UID: 377707).

Synonym(s): bA100C15.2; EIEE14; ENFL5; KCa4.1; SLACK; Slo2.2

The KCNT1 gene is associated with autosomal dominant nocturnal frontal lobe epilepsy (MedGen UID: 767220) and early infantile epileptic encephalopathy (MedGen UID: 767109).

The KCTD17 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant myoclonic dystonia 26 (DYT26) (MedGen UID: 833970).

Synonym(s): CLN14; EPM3

The KCTD7 gene is associated with autosomal recessive progressive myoclonic epilepsy with or without intracellular inclusions (EPM3), also known as neuronal ceroid lipofuscinosis type 14 (CLN14) (MedGen UID: 388595).

Synonym(s): JARID1C; MRX13; SMCX

The KDM5C gene is associated with X-linked intellectual disability, Claes-Jensen type (MedGen UID: 335139)

Synonym(s): MRX98; XPN

The KIAA2022 gene is associated with X-linked intellectual disability 98 (IDX98) (MedGen UID: 813060).

Synonym(s): ATSV; C2orf20; HSN2C; MRD9; SPG30; UNC104

The KIF1A gene is associated with autosomal recessive hereditary sensory neuropathy type 2C (HSN2C) (MedGen UID: 481798) and autosomal recessive and dominant spastic paraplegia 30 (SPG30) (MedGen UID: 372152). The KIF1A gene is also associated with autosomal dominant intellectual disability 9 (ID9) (MedGen UID: 481913).

Synonym(s): CMT2; CMT2A

The KIF1B gene has preliminary evidence supporting a correlation with autosomal dominant hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes (MedGen UID: 313270).

The KIF1C gene is associated with autosomal recessive hereditary spastic paraplegia (HSP) (MedGen UID: 370750).

Synonym(s): SPG10

The KIF5A gene is associated with autosomal dominant hereditary spastic paraplegia 10 (SPG10) (MedGen UID: 349003).

Synonym(s): KBTBD5

The KLHL40 gene is associated with autosomal recessive nemaline myopathy 8 (NEM8) (MedGen UID: 815539).

Synonym(s): KBTBD10

The KLHL41 gene is associated with autosomal recessive nemaline myopathy 9 (NEM9) (MedGen UID: 816714).

Synonym(s): IPOA8

The KPNA7 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal recessive infantile spasms (PMID: 24045845).

Synonym(s): CAM; CCM1

The KRIT1 gene is associated with autosomal dominant cerebral cavernous malformations (CCM) (MedGen UID: 349362).

L
Synonym(s): HSAS; HSAS1; MASA; MIC5; S10; SPG1

The L1CAM gene is associated with X-linked L1 Syndrome (MedGen UID: 798627), which includes a spectrum of conditions ranging from complicated hereditary spastic paraplegia 1 (SPG1) (MedGen UID: 162894), X-linked hydrocephalus syndrome (HSAS) (MedGen UID: 75552), MASA syndrome (OMIM: 303350) to X-linked complicated corpus callosum agenesis (MedGen UID: 374339). Other L1CAM-related conditions have been reported (OMIM: 308840).

Synonym(s): LAMM

The LAMA2 gene is associated with autosomal recessive LAMA2-related muscular dystrophy (MDC1A) (MedGen UID: 224728).

The LAMA4 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 815265).

The LAMB2 gene is associated with autosomal recessive nephrotic syndrome, type 5 (NPHS5) with or without ocular abnormalities (MedGen UID: 481743), and Pierson syndrome (MedGen UID: 373199). Additionally, the LAMB2 gene has preliminary evidence supporting a correlation with autosomal recessive congenital myasthenic syndrome (PMID: 19251977).

Synonym(s): CD107b; LAMP-2; LAMPB; LGP110

The LAMP2 gene is associated with X-linked Danon disease (MedGen UID: 209235).

Synonym(s): LARGE; MDC1D; MDDGA6; MDDGB6

The LARGE1 gene (formerly known as LARGE) is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A6 (MDDGA6) (MedGen UID: 461764) and type B6 (MDDGB6) (MedGen UID: 373284).

The LAS1L gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with X-linked congenital lethal motor neuron disease (PMID: 24647030).

Synonym(s): CMD1C; ZASP

The LDB3 gene is associated with autosomal dominant myofibrillar myopathy 4 (MFM4) (MedGen UID: 322840). Additionally, the LDB3 gene has preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 2880) and left ventricular noncompaction (LVNC) (MedGen UID: 349005).

Synonym(s): ADLTE; ADPAEF; ADPEAF; EPITEMPIN; EPT; ETL1; IB1099

The LGI1 gene is associated with autosomal dominant lateral temporal lobe epilepsy (ADLTE) (MedGen UID: 325326).

Synonym(s): HGCLAS; HUSSY-01; LAS; LIP1; LS; PDHLD

The LIAS gene is associated with autosomal recessive hyperglycinemia, lactic acidosis, and seizures (HGCLAS), also known as pyruvate dehydrogenase lipoic acid synthetase deficiency (PDHLD) (MedGen UID: 482517).

The LIMS2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive limb-girdle muscular dystrophy (PMID: 25589244).

Synonym(s): SIMPLE

The LITAF gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 1C (CMT1C) (MedGen UID: 331363).

Synonym(s): CMD1A; LGMD1B; LMN1; LMNL1; PRO1

The LMNA gene is associated with a diverse group of disorders affecting skeletal and cardiac muscle including autosomal recessive and dominant Emery-Dreifuss muscular dystrophy type 2 (EDMD2) (MedGen UID: 98048) and type 3 (EDMD3) (MedGen UID: 413212), autosomal dominant limb-girdle muscular dystrophy type 1B (LGMD1B) (MedGen UID: 320400), congenital muscular dystrophy (MedGen UID: 413043), and dilated cardiomyopathy (DCM) (MedGen UID: 258500). It is also associated with autosomal recessive Charcot-Marie-Tooth disease type 2B1 (CMT2B1) (MedGen UID: 343064). Additional LMNA-related conditions have also been reported (OMIM: 150330).

Synonym(s): EPM9; LAMB2; LMN2

The LMNB2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive progressive myoclonic epilepsy 9 (PME9) (PMID: 25954030) and autosomal dominant susceptibility to acquired partial lipodystrophy (APL) (PMID: 16826530, 22768673).

The LMOD3 gene is associated with autosomal recessive nemaline myopathy 10 (NEM10) (MedGen UID: 830573).

The LRP4 gene is associated with autosomal recessive Cenani-Lenz syndactyly syndrome (CLSS) (MedGen UID: 395226). Additionally, the LRP4 gene has preliminary evidence supporting a correlation with Sclerosteosis 2 (PMID: 21471202) and congenital myasthenic syndrome (PMID: 24234652).

The LRRC10 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (PMID: 26017719).

The LRRK2 gene is associated with autosomal dominant Parkinson’s disease 8 (PARK8) (MedGen UID: 339628).

The LRSAM1 gene is associated with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2P (CMT2P) (MedGen UID: 482427).

M
MAG
Synonym(s): GMA; S-MAG; SIGLEC-4A; SIGLEC4A; SPG75

The MAG gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive spastic paraplegia (PMID: 24482476, 26179919).

Synonym(s): DDPAC; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; PPP1R103; TAU

The MAPT gene is associated with a spectrum of related autosomal dominant neurodegenerative disorders including frontotemporal dementia (FTD) (MedGen UID: 83266), Pick disease (MedGen UID: 116020), and progressive supranuclear palsy 1 (PSNP1) (MedGen UID: 21026), collectively known as MAPT-related tauopathies. Additionally, the MAPT gene has preliminary evidence supporting a correlation with susceptibility to late-onset Parkinson’s disease (MedGen UID: 463618) and with autosomal recessive Parkinson-dementia syndrome (MedGen UID: 337962; PMID: 11220749, 14991829).

The MARS gene is associated with autosomal recessive interstitial lung and liver disease (ILLD) (MedGen UID: 815981). Additionally, the MARS gene has preliminary evidence supporting a correlation with autosomal dominant Charcot-Marie-Tooth disease type 2U (CMT2U) (PMID: 23729695).

Synonym(s): ALS21; MPD2; VCPDM

The MATR3 gene is associated with autosomal dominant distal myopathy 2 (MPD2) (MedGen UID: 342950). In addition, the MATR3 gene has preliminary evidence for a correlation with autosomal dominant amyotrophic lateral sclerosis 21 (ALS21) (PMID: 26493020, 25771394, 24686783).

Synonym(s): MRD1

The MBD5 gene is associated with autosomal dominant intellectual disability (MedGen UID: 409857). Additionally, the MBD5 gene has preliminary evidence supporting a correlation with autosomal dominant autism spectrum disorder (ASD) (PMID: 23632792, 23055267).

Synonym(s): AUTSX3; MRX16; MRX79; MRXS13; MRXSL; PPMX; RS; RTS; RTT

The MECP2 gene is associated with X-linked dominant Rett syndrome / atypical Rett syndrome (MedGen UID: 48441) and X-linked intellectual disability (MedGen UID: 337496).

Synonym(s): ARC240; CAGH45; FGS1; HOPA; MED12S; OHDOX; OKS; OPA1; TNRC11; TRAP230

The MED12 gene is associated with X-linked recessive Lujan-Fryns syndrome (LFS) (MedGen UID: 167096), Opitz-Kaveggia syndrome (OKS) (MedGen UID: 113106), and Ohdo syndrome (MedGen UID: 785805). Additionally, the MED12 gene has preliminary evidence supporting a correlation with X-linked recessive intellectual disability (ID) (PMID: 26273451, 25644381).

The MED25 gene is associated with autosomal recessive Charcot-Marie-Tooth disease type 2B2 (CMT2B2) (MedGen UID: 381352).

Synonym(s): C5DELq14.3; DEL5q14.3

The MEF2C gene is associated with autosomal dominant MEF2C-related intellectual disability (MedGen UID: 462050).

The MEGF10 gene is associated with autosomal recessive early-onset myopathy, areflexia, respiratory distress and dysphasia (EMARDD) (MedGen UID: 482309).

The MFN2 gene is associated with autosomal dominant and autosomal recessive Charcot-Marie-Tooth disease type 2A2 (MedGen UID: 373098).

Synonym(s): CCMD; CLN7

The MFSD8 gene is associated with autosomal recessive neuronal ceroid lipofuscinosis type 7 (CLN7) (MedGen UID: 325457).

The MORC2 gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2Z) (MedGen UID: 851963).

MPZ
Synonym(s): CMT1; CMT1B

The MPZ gene is associated with autosomal dominant Charcot-Marie-Tooth disease types 1B (CMT1B) (MedGen UID: 124377), 2I (CMT2I) (MedGen UID: 334363), 2J (CMT2J) (MedGen UID: 375107), and dominant intermediate Charcot-Marie-Tooth disease (DI-CMTD) (MedGen UID: 334318).

The MTM1 gene is associated with X-linked centronuclear myopathy (XLCNM) (MedGen UID: 98374).

Synonym(s): CMT4B

The MTMR2 gene is associated with autosomal recessive Charcot-Marie-Tooth disease type 4B1 (CMT4B1) (MedGen UID: 321947).

The MTO1 gene is associated with autosomal recessive combined oxidative phosphorylation deficiency (MedGen UID: 766443).

Synonym(s): FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS

The MTOR gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant familial focal epilepsy with variable foci (PMID: 26302787) and early infantile epileptic encephalopathy (PMID: 23934111).

The MUSK gene is associated with autosomal recessive congenital myasthenic syndrome 9 (CMS9) (MedGen UID: 833690) and fetal akinesia deformation sequence (FADS) (MedGen UID: 220903).

Synonym(s): CMH4

The MYBPC3 gene is associated with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 350526), dilated cardiomyopathy (DCM) (MedGen UID: 2880), and left ventricular noncompaction cardiomyopathy (LVNC) (MedGen UID: 349005).

Synonym(s): Herculin

The MYF6 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant centronuclear myopathy 3 (CNM3) (MedGen UID: 482333).

The MYH2 gene is associated with autosomal recessive inclusion body myopathy type 3 (MYPOP) (MedGen UID: 381340). Additionally, the MYH2 gene has preliminary evidence supporting a correlation with autosomal dominant MYPOP (PMIDs: 23489661, 9708547).

Synonym(s): alpha-MHC; ASD3; CMD1EE; CMH14; MYHC; MYHCA; SSS3

The MYH6 gene currently has no well-established disease association; however there is preliminary evidence supporting a correlation with autosomal dominant atrial septal defects (MedGen UID:371845), hypertrophic cardiomyopathy (HCM) (MedGen UID: 442484), and dilated cardiomyopathy (DCM) (MedGen UID: 412965). Additional MYH6-related conditions have been reported (OMIM: 160710).

Synonym(s): CMH1; MPD1

The MYH7 gene is associated with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 501195), dilated cardiomyopathy (DCM) (MedGen UID: 37831), left ventricular noncompaction (LVNC) (MedGen UID: 349005), and Laing distal myopathy (MPD1) (MedGen UID: 449370). It is also associated with autosomal dominant and recessive myosin storage myopathy (MSMA) (MedGen UID:374868). Additional MYH7-related conditions have also been reported (OMIM: 160760).

The MYL2 gene is associated with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 331754) and autosomal recessive early-onset MYL2-associated light chain myopathy (PMID: 23365102).

The MYL3 gene is associated with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 324806).

The MYLK2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 501195).

The MYOM1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant hypertrophic cardiomyopathy (HCM) (PMID: 21256114).

Synonym(s): LGMD1; LGMD1A; TTID

The MYOT gene is associated autosomal dominant myofibrillar myopathy 3 (MFM3) (MedGen UID: 322957) and limb-girdle muscular dystrophy type 1A (LGMD1A) (MedGen UID: 331802). Other MYOT-related conditions have been reported (OMIM: 604103).

Synonym(s): C4orf5

The MYOZ2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant hypertrophic cardiomyopathy (HCM) (MedGen UID: 462554).

Synonym(s): CMD1DD; CMH22; MYOP; RCM4

The MYPN gene is associated with autosomal recessive nemaline myopathy (PMID:28017374). Additionally, the MYPN gene has preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 490120), hypertrophic cardiomyopathy (HCM) (OMIM: 615248), and restrictive cardiomyopathy RCM (OMIM: 615248).

N
Synonym(s): CAP43

The NDRG1 gene is associated with autosomal recessive Charcot-Marie-Tooth disease type 4D (CMT4D) (MedGen UID: 371304).

NEB
Synonym(s): NEM2

The NEB gene is associated with autosomal recessive nemaline myopathy 2 (NEM2) (MedGen UID: 342534).

The NEBL gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (PMID: 20951326).

Synonym(s): EIEE21

The NECAP1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive early infantile epileptic encephalopathy 21 (EIEE21) (PMID: 24399846).

Synonym(s): hNEDD4-2; NEDD4-2; NEDD4.2; RSP5

The NEDD4L gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant early infantile epileptic encephalopathy (PMID: 23934111).

The NEFL gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2E (CMT2E) (MedGen UID: 375127) and type 1F (CMT1F) (MedGen UID: 334337). There is some evidence for recessive inheritance as well (PMID: 20039262).

The NEXN gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 413929) and hypertrophic cardiomyopathy (HCM) (MedGen UID: 462617).

NGF

The NGF gene is associated with autosomal recessive hereditary sensory and autonomic neuropathy type 5 (HSAN5) (MedGen UID: 6916).

Synonym(s): CDDG; CDG1V; PNG1; PNGase

NGLY1 is associated with autosomal recessive NGLY1-congenital disorder of glycosylation (CDG-Iv) (MedGen UID 815321).

Synonym(s): bA204B7.2; EPM2A; EPM2B; MALIN

The NHLRC1 gene is associated with autosomal recessive progressive myoclonic epilepsy (Lafora disease) (MedGen UID: 155631).

Synonym(s): SPG6

The NIPA1 gene is associated with autosomal dominant hereditary spastic paraplegia 6 (SPG6) (MedGen UID: 324965).

Synonym(s): CHNG5; CSX; CSX1; HLHS2; NKX2.5; NKX2E; NKX4-1; VSD3

The NKX2-5 gene is associated with autosomal dominant tetralogy of Fallot (MedGen UID: 21498), conotruncal heart malformations (MedGen UID: 341803), hypoplastic left heart (MedGen UID: 482415), and atrial septal defect with or without atrioventricular conduction defects (MedGen UID: 400040). Additionally, the NKX2-5 gene has preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (PMID: 23661673), atrial fibrillation (MedGen UID: 445), and congenital hypothyroidism (MedGen UID: 482425).

Synonym(s): HTX5

The NODAL gene is associated with autosomal dominant heterotaxy (MedGen UID: 501198). Additionally, the NODAL gene has preliminary evidence supporting a correlation with autosomal dominant holoprosencephaly (MedGen UID: 38214; PMID: 19553149).

Synonym(s): ANP; PND

The NPPA gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant atrial fibrillation (MedGen UID: 394252) and autosomal recessive atrial dilated cardiomyopathy with atrial standstill (PMID: 23275345).

Synonym(s): C16orf35; CGTHBA; HS-40; MARE; NPR3; RMD11

The NPRL3 gene is associated with autosomal dominant focal epilepsy (PMID: 26505888, 26285051).

Synonym(s): Hs.22998; PTHSL2; SCZD17

The NRXN1 gene is associated with autosomal recessive idiopathic generalized epilepsy (PMID: 23294455, 25950944).

The NT5C2 gene is associated with autosomal recessive spastic paraplegia 45 (SPG45) (MedGen UID: 395641).

The NTRK1 gene is associated with autosomal recessive congenital insensitivity to pain with anhidrosis (CIPA), also known as hereditary sensory and autonomic neuropathy type 4 (HSAN4) (MedGen UID: 6915).

O
Synonym(s): ALS12; FIP2; GLC1E; HIP7; HYPL; NRP; TFIIIA-INTP

The OPTN gene is associated with autosomal recessive amyotrophic lateral sclerosis 12 (ALS12) (MedGen UID: 462042). Autosomal dominant inheritance with incomplete penetrance has also been suggested (PMID: 20428114, 21852022, 21217154, 26740678). The OPTN gene is also associated with autosomal dominant primary open angle glaucoma (POAG) (MedGen UID: 87389).

P
Synonym(s): MRD17; SHMS

The c.607C>T, p.Arg203Trp variant in the PACS1 gene is associated with autosomal dominant intellectual disability 17 (ID17) (MedGen UID: 767257). Other variants in the PACS1 gene are not analyzed by this assay.

Synonym(s): C20orf48; HARP; HSS; NBIA1; PKAN

The PANK2 gene is associated with autosomal recessive pantothenate kinase-associated neurodegeneration (PKAN) (MedGen UID: 6708).

Synonym(s): parkin

The PARK2 gene is associated with autosomal recessive Parkinson disease 2 (PARK2) (MedGen UID: 401500).

Synonym(s): DJ1

The PARK7 gene (previously known as DJ1) is associated with autosomal recessive Parkinson’s disease 7 (PARK7) (MedGen UID: 344049).

Synonym(s): EFMR; EIEE9

The PCDH19 gene is associated with X-linked early infantile epileptic encephalopathy (MedGen UID: 338393). PCDH19-related EIEE appears to affect only heterozygous females while sparing obligate carrier males (PMID: 18469813).

Synonym(s): CCM3; TFAR15

The PDCD10 gene is associated with autosomal dominant cerebral cavernous malformations (MedGen UID: 355121).

The PDK3 gene is associated with X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) (MedGen UID: 813037).

The PDLIM3 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (DCM) (PMID: 17254821), hypertrophic cardiomyopathy (HCM) (PMID: 20801532), and arrhythmogenic right ventricular cardiomyopathy (ARVC) (PMID: 11329061).

Synonym(s): ALS18

The PFN1 gene is associated with autosomal dominant amyotrophic lateral sclerosis 18 (ALS18) (MedGen UID: 766633).

Synonym(s): Bst1; ISPD3024; MRT42; SPG67

The PGAP1 gene is associated with autosomal recessive intellectual disability (MedGen UID: 777028). Additionally, the PGA1 gene has preliminary evidence supporting a correlation with autosomal recessive hereditary spastic paraplegia (PMID: 24482476).

Synonym(s): GPI3; MCAHS2; PIG-A; PNH1

The PIGA gene is associated with X-linked recessive multiple congenital anomalies-hypotonia-seizures syndrome 2 (MCAHS2) (MedGen UID: 477139).

Synonym(s): GPI7; LAS21; MRT53; PRO4405; RLGS1930

The PIGG gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive intellectual disability 53 (ID53) (PMID: 26996948).

Synonym(s): MCAHS; MCAHS1; MCD4; MDC4; PIG-N

The PIGN gene is associated with autosomal recessive multiple congenital anomalies-hypotonia-seizures syndrome 1 (MedGen UID: 481405).

Synonym(s): HPMRS2

The PIGO gene is associated with autosomal recessive hyperphosphatasia with intellectual disability syndrome (MedGen UID: 766551).

Synonym(s): c407A10.1; GPI1

The PIGQ gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with an autosomal recessive seizure disorder (PMID: 24463883).

Synonym(s): BCAP

The PIK3AP1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with infantile spasms (PMID: 25262651).

The PINK1 gene is associated with autosomal recessive early-onset Parkinson’s disease 6 (PARK6) (MedGen UID: 342982).

The PKP2 gene is associated with autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) (MedGen UID: 373205), Brugada syndrome (PMID: 24352520) and dilated cardiomyopathy (DCM) (PMID: 20716751).

Synonym(s): CaI-PLA2; GVI; INAD1; iPLA2; IPLA2-VIA; iPLA2beta; NBIA2; NBIA2A; NBIA2B; PARK14; PLA2; PNPLA9

The PLA2G6 gene is associated with autosomal recessive neuroaxonal dystrophy (MedGen UID: 82852), dystonia-parkinsonism (MedGen UID: 414488) and autosomal recessive neurodegeneration with brain iron accumulation (NBIA) (MedGen UID: 448017).

Synonym(s): EIEE12; PI-PLC; PLC-154; PLC-beta-1; PLC-I; PLC154; PLCB1A; PLCB1B

The PLCB1 gene is associated with autosomal recessive early infantile epileptic encephalopathy (MedGen UID: 462338).

Synonym(s): EBS1; PLEC1

The PLEC gene is associated with autosomal recessive epidermolysis bullosa simplex with muscular dystrophy (EBSMD) (MedGen UID: 347335), epidermolysis bullosa simplex with pyloric atresia (EBSPA) (MedGen UID: 436922), epidermolysis bullosa simplex with myasthenic syndrome (EBSMS) (PMID: 21263134), and limb-girdle muscular dystrophy type 2Q (LGMD2Q) (MedGen UID: 462339). It is also associated with autosomal dominant epidermolysis bullosa simplex, Ogna type (EBSOG) (MedGen UID: 98488).

The PLEKHG5 gene is associated with autosomal recessive intermediate Charcot-Marie-Tooth disease type C (CMTRIC) (MedGen UID: 815639) and distal hereditary motor neuropathy, also known as distal spinal muscular atrophy 4 (DSMA4) (MedGen UID: 369682).

Synonym(s): KIAA0842; SKIP

The PLEKHM2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive dilated cardiomyopathy and left ventricular noncompaction (PMID: 26464484).

PLN
Synonym(s): PLB

The PLN gene is associated with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 322782), hypertrophic cardiomyopathy (HCM) (MedGen UID: 462615), and arrhythmogenic right ventricular cardiomyopathy (ARVC) (PMID: 22820313).

Synonym(s): PLP; SPG2

The PLP1 gene is associated with a spectrum of X-linked conditions, ranging from X-linked hereditary spastic paraplegia 2 (SPG2) (MedGen UID: 374177) to Pelizaeus-Merzbacher disease (PMD) (MedGen UID: 61440).

Pathogenic variants in the PMP22 gene are associated with autosomal dominant Charcot-Marie-Tooth disease type 1A (CMT1A) (MedGen UID: 75727) and 1E (CMT1E) (MedGen UID: 348419) as well as autosomal dominant hereditary neuropathy with liability to pressure palsies (HNPP) (MedGen UID: 98291).

Synonym(s): BRP17; DYT8; FKSG19; FPD1; KIPP1184; MR-1; MR1; PDC; PKND1; TAHCCP2

The PNKD gene is associated with autosomal dominant familial paroxysmal nonkinesigenic dyskinesia (PNKD) (MedGen UID: 401504).

Synonym(s): AOA4; EIEE10; MCSZ; PNK

The PNKP gene is associated with autosomal recessive early infantile epileptic encephalopathy (MedGen UID: 462017) and ataxia with oculomotor apraxia (PMID:25728773).

The PNPLA2 gene is associated with autosomal recessive neutral lipid storage disease with myopathy (NLSDM) (MedGen UID: 339913).

The PNPLA6 gene is associated with a spectrum of autosomal recessive neurological conditions, including hereditary spastic paraplegia 39 (SPG39) (MedGen UID: 383142), Boucher-Neuhauser syndrome (BNHS) (MedGen UID: 347798), Oliver-McFarlane syndrome (OMCS) (MedGen UID: 338532), and Lawrence-Moon syndrome (LNMS) (MedGen UID: 44078).

Synonym(s): HEL-S-302; PDXPO

The PNPO gene is associated with autosomal recessive pyridoxal 5’-phosphate-dependent epilepsy (MedGen UID: 350498).

Synonym(s): MDP1; MIRAS; MTDPS4A; MTDPS4B; PEO; POLG1; POLGA; SANDO; SCAE

The POLG gene is associated with a spectrum of related autosomal recessive conditions (MedGen UID: 60012) including mitochondrial DNA depletion syndrome 4A (Alpers type; MTDPS4A), mitochondrial DNA depletion syndrome 4B (MNGIE type; MTDPS4B), sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (SANDO), spinocerebellar ataxia with epilepsy (SCAE), and progressive external ophthalmoplegia with mitochondrial DNA deletions 1 (PEOB1). In addition, the POLG gene is associated with autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1 (PEOA1)(MedGen UID: 371919).

Synonym(s): GnT I.2; gnT-I.2; GNTI.2; LGMD2O; MDDGA3; MDDGB3; MDDGC3; MEB; MGAT1.2

The POMGNT1 gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A3 (MDDGA3) (MedGen UID: 462869), type B3 (MDDGB3) (MedGen UID: 461762) and type C3 (MDDGC3) (MedGen UID: 461767).

Synonym(s): AGO61; C3orf39; GTDC2; MDDGA8

The POMGNT2 gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A8 (MDDGA8) (MedGen UID: 766727).

Synonym(s): MDDGA12; MDDGC12; SGK196

The POMK gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A12 (MDDGA12) (MedGen UID: 815294) and type C12 (MDDGC12) (MedGen UID: 808099).

Synonym(s): LGMD2K; MDDGA1; MDDGB1; MDDGC1; RT

The POMT1 gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A1 (MDDGA1) (MedGen UID: 75553), type B1 (MDDGB1) (MedGen UID: 461765) and type C1 (MDDGC1) (MedGen UID: 332193).

Synonym(s): LGMD2N; MDDGA2; MDDGB2; MDDGC2

The POMT2 gene is associated with autosomal recessive muscular dystrophy-dystroglycanopathy type A2 (MDDGA2) (MedGen UID: 461761), type B2 (MDDGB2) (MedGen UID: 461766) and type C2 (MDDGC2) (MedGen UID: 461768).

Synonym(s): CLN1; INCL; PPT

The PPT1 gene is associated with autosomal recessive forms of neuronal ceroid lipofuscinosis 1 (CLN1) (MedGen UID: 340540).

The PRDM12 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive hereditary sensory and autonomic neuropathy type VIII (PMID: 26005867).

The PRDM16 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant left ventricular noncompaction (LVNC) (MedGen UID: 349005) and dilated cardiomyopathy (DCM) (OMIM: 615373).

Synonym(s): EPM10; PFM5

The PRDM8 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive progressive myoclonic epilepsy (PMID: 22961547).

The PREPL gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive congenital myasthenic syndrome (CMS) (PMID: 24610330).

Synonym(s): EPM1B; RILP

The PRICKLE1 gene is associated with autosomal recessive progressive myoclonic epilepsy with ataxia (MedGen UID: 394003).

Synonym(s): EPM5

The PRICKLE2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant progressive myoclonic epilepsy 5 (PMID: 21276947, 23711981).

Synonym(s): PRIMA

The PRIMA1 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive nocturnal frontal lobe epilepsy (PMID: 26339676).

The PRKAG2 gene is associated with autosomal dominant glycogen storage related Wolff-Parkinson-White syndrome (MedGen UID: 12162) with or without hypertrophic cardiomyopathy (HCM) (MedGen UID: 331466).

The PRKRA gene is associated with autosomal recessive dystonia 16 (DYT16) (MedGen UID: 436979).

Synonym(s): AltPrP; ASCR; CD230; CJD; GSS; KURU; p27-30; prion protein (p27-30); PRIP; PrP; PrP27-30; PrP33-35C; PrPc

The PRNP gene is associated with a spectrum of autosomal dominant neurodegenerative disorders including Creutzfeldt-Jakob disease (CJD) (MedGen UID: 7179), Gerstmann-Straussler-Scheinker (GSS) syndrome (MedGen UID: 4886), and fatal familial insomnia (FFI) (MedGen UID: 104768), collectively known as genetic prion diseases.

Synonym(s): DFN2

The PRPS1 gene is associated with X-linked Charcot-Marie-Tooth disease type 5 (CMTX5) (MedGen UID: 374254).

Synonym(s): BFIC2; BFIS2; DSPB3; DYT10; EKD1; FICCA; ICCA; IFITMD1; PKC

The PRRT2 gene is associated with a spectrum of related autosomal dominant neurological conditions (MedGen UID: 358268) including episodic kinesigenic dyskinesia 1 (EKD1), benign familial infantile seizures 2 (BFIS2), and familial infantile convulsions with paroxysmal choreoathetosis (ICCA).

PRX

The PRX gene is associated with autosomal recessive Charcot-Marie-Tooth disease type 4F (CMT4F) (MedGen UID: 761704).

Synonym(s): AD3; FAD; PS-1; PS1; S182

The PSEN1 gene is associated with autosomal dominant Alzheimer’s disease type 3 (AD3) (MedGen UID: 334304) and familial acne inversa type 3 (ACNINV3) (MedGen UID: 462388). Additionally, the PSEN1 gene has preliminary evidence supporting a correlation with autosomal dominant dilated cardiomyopathy (MedGen UID: 463620) and frontotemporal dementia (FTD) (MedGen UID: 83266; PMID: 11094121).

Synonym(s): AD3L; AD4; CMD1V; PS2; STM2

The PSEN2 gene is associated with autosomal dominant Alzheimer’s disease type 4 (AD4) (MedGen UID: 376072).

Synonym(s): BCNS; HPE7; NBCCS; PTC; PTC1; PTCH; PTCH11

The PTCH1 gene is associated with autosomal dominant nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome (MedGen UID: 2554). Additionally, the PTCH1 gene has preliminary evidence supporting a correlation with autosomal dominant holoprosencephaly (HPE) (MedGen: 372134).

Synonym(s): 10q23del; BZS; CWS1; DEC; GLM2; MHAM; MMAC1; PTEN1; TEP1

The PTEN gene is associated with autosomal dominant PTEN hamartoma tumor syndrome (PHTS) including the clinical subtypes of Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, and Proteus-like syndrome (MedGen UID: 368366).

Synonym(s): MRD31; PUR-ALPHA; PUR1; PURALPHA

The PURA gene is associated with autosomal dominant intellectual disability 31 (IDD31) and with neonatal hypotonia, seizures, and encephalopathy (MedGen UID: 830571; PMID: 25439098).

Q
Synonym(s): GLNRS; MSCCA; PRO2195

The QARS gene is associated with autosomal recessive progressive microcephaly with seizures and cerebral and cerebellar atrophy (MedGen UID: 776944).

R

The RAB3GAP2 gene is associated with autosomal recessive Warburg micro syndrome 2 (WARBM2) (MedGen UID: 481844) and Martsolf syndrome (MedGen UID: 208658). Additionally, there is preliminary evidence supporting a correlation with autosomal recessive hereditary spastic paraplegia (HSP) (PMID: 24482476).

Synonym(s): RAB7

The RAB7A gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2B (CMT2B) (MedGen UID: 371512).

Synonym(s): c-Raf; CMD1NN; CRAF; NS5; Raf-1

The RAF1 gene is associated with autosomal dominant Noonan syndrome (MedGen UID: 370589), Noonan syndrome with multiple lentigines (NSML) (MedGen UID: 370588), and dilated cardiomyopathy (MedGen UID: 807537).

Synonym(s): ADANE; ANE1; IIAE3; NUP358; TRP1; TRP2

The RANBP2 gene is associated with autosomal dominant infection-induced acute necrotizing encephalopathy (MedGen UID: 382634).

The RAPSN gene is associated with autosomal recessive congenital myasthenic syndrome 11 (CMS11) (MedGen UID: 323066) and fetal akinesia deformation sequence (FADS) (MedGen UID: 220903).

Synonym(s): 2BP1; A2BP1; FOX-1; FOX1; HRNBP1

The RBFOX1 gene is associated with autosomal dominant idiopathic generalized epilepsy (PMID: 23350840, 24039908, 25950944, 26174448).

Synonym(s): FOX-3; FOX3; HRNBP3; NEUN

The RBFOX3 gene currently has no well-established disease association; however, there is limited evidence supporting a correlation with autosomal dominant idiopathic generalized epilepsy (PMID: 24603971, 24039908).

The RBM20 gene is associated with autosomal dominant dilated cardiomyopathy (DCM) (MedGen UID: 416441).

Synonym(s): C2orf23

The REEP1 gene is associated with autosomal dominant hereditary spastic paraplegia 31 (SPG31) (MedGen UID: 377858) and distal hereditary motor neuropathy 5B (HMN5B) (MedGen UID: 766570).

The REEP2 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal recessive and autosomal dominant hereditary spastic paraplegia 72 (SPG72) (PMID: 24388663).

Synonym(s): ETL7; LIS2; PRO1598; RL

The RELN gene is associated with autosomal recessive lissencephaly (MedGen UID: 163213).

Synonym(s): KTZS

The ROGDI gene is associated with autosomal recessive Kohlschutter’s syndrome (MedGen UID: 98036).

Synonym(s): SPG12

The RTN2 gene is associated with autosomal dominant hereditary spastic paraplegia 12 (MedGen UID: 347618).

Synonym(s): CCO; MHS; MHS1

The RYR1 gene is associated with autosomal recessive and dominant central core disease (CCD) (MedGen UID: 199773) and autosomal recessive congenital myopathy with fiber-type disproportion (CFTD) (MedGen UID: 108177) and multiminicore disease (MmD) (MedGen UID: 388775). It is also associated with autosomal dominant centronuclear myopathy (CNM) (MedGen UID: 799613) and malignant hyperthermia susceptibility type 1 (MHS1) (MedGen UID: 833963).

Synonym(s): ARVD2

The RYR2 gene is associated with autosomal dominant catecholaminergic polymorphic ventricular tachycardia (CPVT) (MedGen UID: 351513), arrhythmogenic right ventricular cardiomyopathy (ARVC) (MedGen UID: 318748) and left ventricular noncompaction (LVNC) (PMID: 24394973).

Synonym(s): RYR-3

The RYR3 gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant epileptic encephalopathy (PMID: 25262651).

S

The SACS gene is associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) (MedGen UID: 338620).

Synonym(s): GLSS

The SATB2 gene is associated with autosomal dominant Glass syndrome (MedGen UID: 436765).

Synonym(s): CMT4B2

The SBF2 gene is associated with autosomal recessive Charcot-Marie-Tooth disease type 4B2 (CMT4B2) (MedGen UID: 346869).

Synonym(s): AMRF; CD36L2; EPM4; HLGP85; LGP85; LIMP-2; LIMPII; SR-BII

The SCARB2 gene is associated with autosomal recessive progressive myoclonic epilepsy, with or without renal failure (MedGen UID: 155629).

The SCN10A gene currently has no well-established disease association; however, there is preliminary evidence supporting a correlation with autosomal dominant small fiber neuropathy (SFNP) (PMID: 23986244) and Brugada syndrome (BrS) (PMID: 24998131).

The SCN11A gene is associated with autosomal dominant hereditary sensory and autonomic neuropathy type 7 (HSAN7) (MedGen UID: 816212) and familial episodic pain syndrome type 3 (FEPS3) (MedGen UID: 816229).

Synonym(s): EIEE6; FEB3; FEB3A; FHM3; GEFSP2; HBSCI; NAC1; Nav1.1; SCN1; SMEI

The SCN1A gene is associated with a spectrum of autosomal dominant SCN1A-related seizure disorders ranging from simple febrile seizures (MedGen UID: 338959) and generalized epilepsy with febrile seizures plus (GEFS+) (MedGen UID: 388117) to Dravet syndrome (MedGen UID: 148243) and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) (MedGen UID: 148243). Other SCN1A-related conditions have been reported (OMIM: 607208).

Synonym(s): ATFB13; BRGDA5; GEFSP1

The SCN1B gene is associated with autosomal dominant generalized epilepsy with febrile seizures (MedGen UID: 348994). Additionally, the SCN1B gene has preliminary evidence supporting a correlation with autosomal dominant Brugada syndrome (BrS) (MedGen UID: 411607), atrial fibrillation (MedGen UID: 334469), cardiac conduction disease (PMID: 18464934) and autosomal recessive early infantile epileptic encephalopathy (PMID: 19710327).

Synonym(s): BFIC3; BFIS3; BFNIS; EIEE11; HBA; HBSCI; HBSCII; Na(v)1.2; NAC2; Nav1.2; SCN2A1; SCN2A2

The SCN2A gene is associated with autosomal dominant benign familial neonatal-infantile seizures (BFNIS) (MedGen UID: 375105), early infantile epileptic encephalopathy (EIEE) (MedGen UID: 462337), intellectual disability (ID)(PMID: 23020937) and autism spectrum disorder (ASD)(PMID: 22495306).